var title_f1_55_1904="Syndesmotic sprain";
var content_f1_55_1904=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61181&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Syndesmotic sprain",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 424px; height: 304px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A syndesmotic sprain can be caused by dorsiflexion and eversion of the ankle with internal rotation of the tibia as shown by the picture on the right. The figure on the left shows a posterior view with injury to the posterior tibiofibular ligament. The anterior tibiofibular ligament cannot be seen in this view but would also be damaged by the injury.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1904=[""].join("\n");
var outline_f1_55_1904=null;
var title_f1_55_1905="Duck bill weighted retractor";
var content_f1_55_1905=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Duck-billed weighted retractor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 258px; height: 441px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This retractor can be inserted into the opened posterior cul-de-sac during vaginal hysterectomy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1905=[""].join("\n");
var outline_f1_55_1905=null;
var title_f1_55_1906="Congenital muscular torticollis";
var content_f1_55_1906=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78313&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital muscular torticollis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 379px; height: 401px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) There is a fibrous mass in the right sternocleidomastoid muscle (arrow).",
"    <br>",
"     (B) Rotation toward the right is limited by the tightness in the right sternocleidomastoid muscle.",
"     <br>",
"      (C) Rotation toward the left is normal.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Reproduced with permission from: MacDonald MG, Seshia MM, et al. Avery's Neonatology Pathophysiology and Management of the Newborn, 6th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2005. Copyright &copy; 2005 Lippincott Williams &amp; Wilkins.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1906=[""].join("\n");
var outline_f1_55_1906=null;
var title_f1_55_1907="Palpable purpura";
var content_f1_55_1907=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77522&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Palpable purpura in cutaneous small vessel vasculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Palpable purpura are present in this patient with cutaneous small vessel vasculitis secondary to Henoch-Sch&ouml;nlein purpura (IgA vasculitis).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1907=[""].join("\n");
var outline_f1_55_1907=null;
var title_f1_55_1908="Pediatric position for ventilation and intubation";
var content_f1_55_1908=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69636&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Proper positioning for ventilation and intubation for children older than two years of age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 505px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) The oral (O), tracheal (T), and pharyngeal (P) axes are in divergent planes. B) A towel under the occiput brings the external auditory canal anterior to the shoulder, aligning the T and P axes. C) The extension of the head on the neck, with the mouth and nose facing the ceiling, aligns the O axis with the T and P axes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1908=[""].join("\n");
var outline_f1_55_1908=null;
var title_f1_55_1909="Nevus of Ota";
var content_f1_55_1909=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F77921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F77921&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Nevus of Ota (oculodermal melanocytosis, nevus fuscocaeruleus ophthalmomaxillaris)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mottled blue-black patch in the left periorbital area, with involvement of the conjunctiva and sclera of the left eye.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jean L Bolognia, MD, and Julie V Schaffer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1909=[""].join("\n");
var outline_f1_55_1909=null;
var title_f1_55_1910="Contact dermatitis feet";
var content_f1_55_1910=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51220&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Shoe allergic contact dermatitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Stedman's Medical Dictionary. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1910=[""].join("\n");
var outline_f1_55_1910=null;
var title_f1_55_1911="Normal fetal nasal bone";
var content_f1_55_1911=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59173%7EOBGYN%2F51069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59173%7EOBGYN%2F51069&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Normal fetal nasal bone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 352px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When the fetal profile is viewed in the midsagittal plane, the nasal bone synostosis appears as a thin echogenic line within the bridge of the nose. The nasal bone is considered present if this line is more echogenic than the overlying skin, and absent if it is not visualized, or less echogenic, than the overlying skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beryl R Benacerraf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Absent nasal bone",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 296px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Profile of a second trimester Down Syndrome fetus with absent nasal bone ossification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Beryl R Benacerraf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1911=[""].join("\n");
var outline_f1_55_1911=null;
var title_f1_55_1912="Rapid sequence intubation in adults";
var content_f1_55_1912=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Rapid sequence intubation in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Aaron E Bair, MD, MSc, FAAEM, FACEP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Ron M Walls, MD, FRCPC, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1912/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/55/1912/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first task of any clinician managing an acutely unstable patient is to secure the airway. In most circumstances, emergency clinicians use rapid sequence intubation (RSI) to accomplish this task. RSI incorporates a rapidly acting sedative (ie, induction) agent and a neuromuscular blocking (ie, paralytic) agent to create optimal intubating conditions and enable rapid control of the airway. RSI presupposes the patient is at risk for aspiration of stomach contents and incorporates medications and techniques to minimize this risk. Use of RSI also helps to mitigate the potential adverse effects of airway manipulation.",
"   </p>",
"   <p>",
"    This topic review will discuss the central concepts and techniques needed to perform rapid sequence intubation in adults. Discussions of RSI in children, the medications used for RSI, and other subjects related to emergency airway management are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link\">",
"     \"Rapid sequence intubation (RSI) in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=see_link\">",
"     \"Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38775?source=see_link\">",
"     \"Pretreatment agents for rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) is the virtually simultaneous administration of a sedative and a neuromuscular blocking (paralytic) agent to render a patient rapidly unconscious and flaccid in order to facilitate emergent endotracheal intubation and to minimize the risk of aspiration. Preoxygenation is required to permit a longer period of apnea without clinically significant oxygen desaturation. Bag-mask ventilation is avoided during the interval between drug administration and endotracheal tube placement, thereby minimizing gastric insufflation and reducing the risk of aspiration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) is the standard of care in emergency airway management for intubations not anticipated to be difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. Multiple large prospective observational studies confirm that the implementation of RSI has led to improved success and decreased complication rates for emergency intubations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/1-6\">",
"     1-6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to rapid sequence intubation (RSI) are relative. Circumstances exist where neuromuscular blockade is undesirable due to the high likelihood of intubation or mechanical ventilation failure. Depending on clinical circumstances, particular sedative or neuromuscular blocking agents may be relatively contraindicated, due to the risk of potential side effects. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Induction agents'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H11\">",
"     'Neuromuscular blocking agents'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DESCRIPTION OF THE TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) depends on preparation and detailed considerations at multiple steps. The \"Seven P's of RSI\" is a mnemonic that outlines these key steps (",
"    <a class=\"graphic graphic_table graphicRef77060 \" href=\"UTD.htm?12/11/12475\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preparation",
"     </li>",
"     <li>",
"      Preoxygenation",
"     </li>",
"     <li>",
"      Pretreatment",
"     </li>",
"     <li>",
"      Paralysis with induction",
"     </li>",
"     <li>",
"      Protection and positioning",
"     </li>",
"     <li>",
"      Placement with proof",
"     </li>",
"     <li>",
"      Postintubation management",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Each step is discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preparation includes assessing the patient's airway, developing an airway management plan, and assembling necessary equipment and medications (",
"    <a class=\"graphic graphic_table graphicRef79150 \" href=\"UTD.htm?25/44/26315\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Once the need for intubation is determined, the clinician assesses the patient for anatomic features or clinical findings that indicate the patient may be difficult to intubate or to ventilate using a bag-mask. Although the presence of markers for difficult intubation or difficult bag-mask ventilation is not an absolute contraindication to RSI, if such features are identified, alternatives to rapid sequence intubation (RSI) may be needed. Alternatives include an \"awake technique\" in which the patient is lightly to moderately sedated and intubated using topical anesthesia, but is not induced and paralyzed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=see_link\">",
"     \"The decision to intubate\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Prior to proceeding with RSI, at least one, but preferably two, functioning intravenous line should be in place, and cardiac, pulse oximetry, and blood pressure monitors should be in place. The patient should be in an appropriate area within the emergency department where necessary airway and resuscitation equipment are available. The airway manager should have easy access to the head of the bed, and should adjust the height of the bed and position of the patient to facilitate intubation.",
"   </p>",
"   <p>",
"    The airway manager verifies that endotracheal tubes of appropriate sizes are available and their cuffs are free of leaks. A stylette is placed in the tube. If a conventional laryngoscope is to be used, its light must be working and both curved and straight blades of different sizes (generally Macintosh and Miller sizes 2, 3, and 4) should be available. Suction devices are checked and ready for immediate use. A bag-mask and both oral and nasal pharyngeal airways should be at the bedside. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link\">",
"     \"Basic airway management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinician selects the induction and paralytic agents (and pretreatment medications if desired) to be used and determines the doses. Allergies and potential contraindications should be considered carefully. The medications to be used are drawn up into labeled syringes.",
"   </p>",
"   <p>",
"    A critical and often overlooked part of this initial phase of RSI is preparation for unanticipated difficulty. An assessment of airway difficulty should be performed before the decision is made to proceed with RSI. Even if there are no indicators of difficult intubation identified and the intubation appears likely to be routine, the airway manager must have a backup plan to manage unanticipated problems with intubation or bag-mask ventilation. Backup plans will vary with the clinical situation, the availability of devices, and the training of the provider. Equipment necessary to implement the backup plan should be at the bedside. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=see_link\">",
"     \"The difficult airway in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Preoxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Any patient who may require urgent tracheal intubation should immediately be given high flow oxygen at the highest possible concentration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/9\">",
"     9",
"    </a>",
"    ]. This is typically done using a facemask with an oxygen reservoir (often referred to as a &ldquo;nonrebreather&rdquo; facemask, although it does not provide oxygen concentrations as high as a true nonrebreather mask, such as a bag-mask resuscitator device with a one-way exhalation valve). Alternatively, 8 vital capacity breaths may be used in cooperative patients and will provide equivalent pre-oxygenation in less than one minute.",
"   </p>",
"   <p>",
"    Additional strategies to prevent oxygen desaturation during emergency airway management include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/9\">",
"     9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients not immobilized for possible spinal injury, oxygenation is improved by placing them in a 20 degree head-up position [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/10-12\">",
"       10-12",
"      </a>",
"      ]. Alternatively, 30 degree reverse Trendelenburg positioning (bed kept straight but angled with patient&rsquo;s head up) may be used for immobilized patients. The benefits of the head-up position for obese patients are discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20329?source=see_link&amp;anchor=H14#H14\">",
"       \"Emergency airway management in the morbidly obese patient\", section on 'Preoxygenation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      During the apneic period of RSI, provide oxygen via nasal cannula at a flow rate of 5",
"      <span class=\"nowrap\">",
"       L/minute.",
"      </span>",
"      This technique extends the period of adequate oxygen saturation during apnea, according to several randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/13,14\">",
"       13,14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      If necessary, patency of the upper airway can be maintained with adjuncts (nasal or oropharyngeal airways) and positioning maneuvers (chin lift",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      jaw thrust). The chin lift is not used when spinal precautions are being observed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link&amp;anchor=H5#H5\">",
"       \"Basic airway management in adults\", section on 'Airway maneuvers'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who are unable to achieve oxygen saturation above 93 percent despite high flow oxygen, and who are judged able to tolerate positive pressure support, pre-oxygenation delivered via a positive pressure device (eg, CPAP) may enhance apnea time [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/15-17\">",
"       15-17",
"      </a>",
"      ]. Disposable positive end-expiratory pressure (PEEP) valves that can be attached to a standard bag-valve mask are available, in addition to standard positive pressure devices. The benefits of positive pressure ventilation to improve preoxygenation in obese patients are reviewed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20329?source=see_link&amp;anchor=H14#H14\">",
"       \"Emergency airway management in the morbidly obese patient\", section on 'Preoxygenation'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinicians may need to adjust the method for providing preoxygenation according to clinical circumstances. However, a period of preoxygenation longer than three to five minutes in critically ill patients is unlikely to provide significant benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/18\">",
"     18",
"    </a>",
"    ]. In cooperative patients capable of taking deep breaths, nitrogen washout can be achieved by having the patient take eight vital capacity (ie, maximal) breaths [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manual ventilation prior to intubation should be reserved for patients who are hypoxic (saturation &lt;91 percent) and if used the provider should be particularly mindful of maintaining a slow rate (approximately 8",
"    <span class=\"nowrap\">",
"     breaths/minute),",
"    </span>",
"    giving a low volume (approximately 8",
"    <span class=\"nowrap\">",
"     mL/kg),",
"    </span>",
"    and avoiding excessive force when ventilating (deliver breath over a full 1 to 2 seconds) to prevent overinflation of the lungs and distension of the stomach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=see_link&amp;anchor=H17#H17\">",
"     \"Basic airway management in adults\", section on 'Ventilation volumes, rates, and cadence'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Giving oxygen in anticipation of rapid sequence intubation (RSI) has several important effects. In addition to improving the patient's oxyhemoglobin saturation, high flow oxygen displaces nitrogen in the patient's lungs. \"Washing out\" the nitrogen and replacing it with oxygen converts the lung's functional residual capacity into an oxygen reservoir. Preoxygenation also increases oxygen stores in the blood and tissues. The combined effect is to enable patients to tolerate a longer period of apnea without oxygen desaturation. Preoxygenation is essential if clinicians are to avoid the need for assisted ventilations interposed between paralysis and placement of the endotracheal tube.",
"   </p>",
"   <p>",
"    Researchers have characterized the expected time to desaturation after apnea is induced in properly preoxygenated patients of various ages and comorbid conditions (",
"    <a class=\"graphic graphic_figure graphicRef56716 \" href=\"UTD.htm?2/58/2976\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/21\">",
"     21",
"    </a>",
"    ]. A healthy 70 kg adult can maintain oxygen saturation above 90 percent for approximately eight minutes. Young children typically fall below the 90 percent threshold in less than four minutes. The oxygen saturation of adults with severe illness or obesity, and pregnant women nearing the end of their third trimester, falls below 90 percent in less than three minutes despite optimal preoxygenation.",
"   </p>",
"   <p>",
"    The important concept is that preoxygenation provides a longer period before clinically significant desaturation, regardless of the patient's condition. The duration of this period varies greatly, depending upon patient attributes, and continuous monitoring of oxyhemoglobin saturation by pulse oximetry is essential. When assessing oxygen saturation, remember that pulse oximetry readings obtained with a finger probe may lag behind the central arterial circulation, particularly in critically ill patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/9,22\">",
"     9,22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Pretreatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pretreatment is the administration of medications prior to the induction phase of rapid sequence intubation (RSI) for the purpose of mitigating adverse effects associated with endotracheal intubation. The drugs used for pretreatment vary with clinical circumstances. Pretreatment agents for RSI are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38775?source=see_link\">",
"     \"Pretreatment agents for rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Paralysis with induction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The concept of rapid sequence intubation (RSI) is based on the virtually simultaneous intravenous administration of a rapidly acting induction agent and a neuromuscular blocking agent (paralytic). Agent selection and dosing are aimed at producing a state of deep sedation and muscular relaxation quickly. RSI does",
"    <strong>",
"     NOT",
"    </strong>",
"    involve titration of either agent to reach this state. The dose of each agent is precalculated to achieve the desired effect. Onset of action after administration is variable depending on the agent chosen, but the goal is to achieve intubation level paralysis and sedation 45 to 60 seconds after the drugs are given by IV push.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Induction agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal RSI induction agent acts quickly to provide a deep state of unconsciousness, as well as analgesia, with limited side effects. No available agent meets this ideal standard. Drugs that have been used as induction agents include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/34/15908?source=see_link\">",
"     etomidate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/45/10967?source=see_link\">",
"     ketamine",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/60/4042?source=see_link\">",
"     midazolam",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/25/17816?source=see_link\">",
"     propofol",
"    </a>",
"    , and short-acting barbiturates (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/63/1015?source=see_link\">",
"     thiopental",
"    </a>",
"    ). The induction agents used for RSI are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"     \"Sedation or induction agents for rapid sequence intubation in adults\"",
"    </a>",
"    .) A summary table of induction agents is provided (",
"    <a class=\"graphic graphic_table graphicRef64272 \" href=\"UTD.htm?35/29/36316\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Neuromuscular blocking agents",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of a neuromuscular blocking agent (NMBA) to produce rapid paralysis comprises the cornerstone of rapid sequence intubation (RSI). Neuromuscular blocking agents do",
"    <strong>",
"     NOT",
"    </strong>",
"    provide analgesia or sedation. In the context of RSI, they are used immediately following an induction agent. The NMBAs used for RSI are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=see_link\">",
"     \"Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Protection (cricoid pressure) and positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;This phase of rapid sequence intubation (RSI) refers to protecting the airway against aspiration prior to placement of the endotracheal tube by avoiding bag-mask ventilation and applying cricoid pressure (Sellick's maneuver). Bag-mask ventilation is unnecessary if the patient has been successfully preoxygenated. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Preoxygenation'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Furthermore, ventilation interposed between paralysis and intubation creates a potential hazard if stomach insufflation results in regurgitation and aspiration. Provided oxygen saturation remains above 90 percent, bag-mask ventilation is unnecessary, even between laryngoscopy attempts. If the patient's saturation percentage falls below 90, or is unknown, clinicians provide ventilatory support using a bag-mask, while maintaining cricoid pressure.",
"   </p>",
"   <p>",
"    Sellick originally described the concept of cricoid pressure as a method to prevent passive regurgitation. A systematic review questions the technique's effectiveness and we consider it optional during RSI [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/23\">",
"     23",
"    </a>",
"    ]. Sellick's maneuver is performed using the thumb and index or middle finger to apply firm downward pressure on the cricoid cartilage thereby compressing the esophagus between the cricoid cartilage and the anterior surface of the vertebral body (",
"    <a class=\"graphic graphic_figure graphicRef71800 \" href=\"UTD.htm?21/53/22354\">",
"     figure 2",
"    </a>",
"    ). A common error is to apply pressure to the thyroid cartilage (Adam's apple).",
"   </p>",
"   <p>",
"    While in practice cricoid pressure is maintained by an assistant, the airway manager directs the application and duration of force being applied. When used, cricoid pressure is applied immediately following induction and maintained until adequate tube placement has been confirmed. Sometimes Sellick's maneuver may obscure the glottic view, impede passage of the endotracheal tube, or prevent adequate ventilation (when ventilation is necessary). If so, the intubator should have the assistant reduce or remove cricoid pressure.",
"   </p>",
"   <p>",
"    Although Sellick's maneuver may reduce gastric insufflation during bag-mask ventilation, evidence that cricoid pressure reduces the incidence of aspiration of gastric contents is scant and consists primarily of observational clinical studies and experimental data [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/23\">",
"     23",
"    </a>",
"    ]. Several studies suggest it may contribute to airway obstruction and difficulty intubating in some cases, even when a video laryngoscope is used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/23-27\">",
"     23-27",
"    </a>",
"    ]. Until more definitive literature is published, we suggest that the use of Sellick's maneuver during RSI and bag-mask ventilation be considered optional.",
"   </p>",
"   <p>",
"    A systematic review of cricoid pressure studies noted the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Case series and retrospective reviews describe both the success and failure of cricoid pressure to prevent aspiration.",
"     </li>",
"     <li>",
"      Cricoid pressure is often used inconsistently and applied improperly in all airway management settings.",
"     </li>",
"     <li>",
"      Cricoid pressure may impair the function of the lower esophageal sphincter.",
"     </li>",
"     <li>",
"      Possible risks from cricoid pressure include movement of unstable cervical spine fractures and esophageal injury.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Placement with proof",
"    </span>",
"    &nbsp;&mdash;&nbsp;After flaccidity is achieved, assessed by masseter muscle tone (ie, laxity of the jaw with no resistance to mouth opening), laryngoscopy can be performed. The time to muscular relaxation will vary depending on the neuromuscular blocking agent used. When used with an appropriate induction agent,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    generally produces excellent intubating conditions within 45 seconds, compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"     rocuronium",
"    </a>",
"    , which requires 60 seconds. The goal of laryngoscopy is direct visualization of the glottic aperture. Once the glottis is visualized, the clinician places the endotracheal tube (ETT) between the vocal cords, inflates the cuff, withdraws the stylette, and confirms placement.",
"   </p>",
"   <p>",
"    Confirmation of proper ETT placement is crucial; unrecognized esophageal intubation leads to devastating complications. End-tidal CO2 (EtCO2) determination (either colorimetric or quantitative) is the most accurate means of confirming ETT placement in most circumstances, and we recommend it be used with every intubation. Clinical indicators alone, such as visualization of the ETT through the cords, misting of the tube with ventilation, and auscultation of breath sounds over the lung fields,",
"    <strong>",
"     cannot",
"    </strong>",
"    be relied upon to confirm proper ETT placement. In cardiac arrest patients not producing CO2, alternative means of confirmation may be needed if CO2 is not detected. A single-view chest x-ray is only useful to determine depth of placement (eg, tracheal versus right mainstem). It is not useful for distinguishing endotracheal from esophageal intubation. The methods for proving proper ETT placement are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=see_link&amp;anchor=H25#H25\">",
"     \"Direct laryngoscopy and tracheal intubation in adults\", section on 'Confirming proper tracheal tube placement'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Postintubation management",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) remains incomplete until the properly placed endotracheal tube is secured. Several techniques are commonly used to secure the tube, including taping, tying, and using proprietary tube-holders. There is some evidence to suggest that a tube stabilizing device may be better tolerated than taping for long-term management [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The technique employed for ED airway management should be readily available, easy to apply, and secure.",
"   </p>",
"   <p>",
"    A post procedural chest x-ray is obtained to confirm depth of tube placement and to evaluate for evidence of barotrauma as a consequence of positive pressure ventilation.",
"   </p>",
"   <p>",
"    Hypotension can occur soon after intubation, often as a result of reduced venous return, because of increased intrathoracic pressure from mechanical ventilation. Lingering effects of the induction agent may contribute. While diminished venous return and sedation are common causes, clinicians should not assume they alone account for patient hypotension and should consider other potentially dangerous causes, including pneumothorax and cardiac ischemia. Initial management of hypotensive episodes consists of boluses of IV crystalloid and careful monitoring of airway pressures. Critically ill patients may be depleted of endogenous catecholamines, causing hypotension, and may require treatment with exogenous catecholamines. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=see_link\">",
"     \"Treatment of severe hypovolemia or hypovolemic shock in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=see_link\">",
"     \"Use of vasopressors and inotropes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Mechanical ventilation is initiated. Ventilator settings may need modification according to clinical circumstance. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=see_link\">",
"     \"Mechanical ventilation of adults in the emergency department\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If long-term paralysis is needed, the timing of subsequent doses of both paralytic and sedative agents should be anticipated. Providing both long-term analgesia and sedation is important given the relatively short duration of action of some of the agents frequently used for RSI and the ability of paralysis to obscure the patient's capacity to communicate pain or distress. Appropriate sedation, guided by a sedation scale, often obviates the need for neuromuscular paralysis to permit mechanical ventilation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     VARIATIONS OF TECHNIQUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The general approach described above is a commonly accepted way of performing rapid sequence intubation (RSI). There are, however, a number of variations, depending on clinical circumstance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Accelerated sequence",
"    </span>",
"    &nbsp;&mdash;&nbsp;The accelerated approach is useful for a critically unstable patient when there is not sufficient time for the full period of preoxygenation. In this case, the time line can be abbreviated by providing eight vital capacity breaths, rather than three to five minutes of tidal volume breathing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/20,31,32\">",
"     20,31,32",
"    </a>",
"    ]. The pretreatment phase can also be accelerated to begin just prior to induction. If the patient is in extremis, the pretreatment phase can be eliminated altogether. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38775?source=see_link\">",
"     \"Pretreatment agents for rapid sequence intubation in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=see_link&amp;anchor=H11#H11\">",
"     \"Rapid sequence intubation (RSI) in children\", section on 'Pretreatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Timing principle",
"    </span>",
"    &nbsp;&mdash;&nbsp;This concept has been described in the anesthesia literature and involves the administration of a relatively slower-onset paralytic agent prior to induction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1912/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. The clinician waits for the early signs of the onset of paralysis before giving the induction agent. The purpose is to coordinate the onset of the paralytic and induction agents. It is possible the patient will experience a period of muscular weakness or paralysis while still awake if this approach is used. For this reason, the technique is not recommended or used in emergency medicine practice.",
"   </p>",
"   <p>",
"    The timing principle should not be confused with the practice of administering a long-acting agent with a slower onset (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/26/19879?source=see_link\">",
"     rocuronium",
"    </a>",
"    ) immediately prior to the induction agent, when both are given in rapid succession. This is done to coordinate the onset of action. The intention is to capitalize on the more rapid onset of the induction agent by giving it after the neuromuscular blocking agent (NMBA), affording the latter a bit more time to take effect.",
"   </p>",
"   <p>",
"    Typically, when performing RSI using",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    , the induction agent is given before the NMBA. The fundamental distinction between the timing principle and this approach is that the clinician does not wait for the onset of paralysis before giving the induction agent, but is merely reversing the order of the induction and paralytic agents to allow for their different times to effect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid sequence intubation (RSI) has become the mainstay of emergency airway management. RSI uses a rapidly acting sedative (ie, induction) and a neuromuscular blocking (ie, paralytic) agent to create optimal intubating conditions and enable rapid control of the airway. RSI presupposes the patient is at risk for aspiration of stomach contents and incorporates medications and techniques to minimize this risk. Use of RSI helps to mitigate the potential adverse effects of airway manipulation. The basic approach to RSI consists of the \"Seven P's\":",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Preparation &ndash; Assess the patient for anatomic features or clinical findings that indicate the patient may be difficult to intubate or to ventilate using a bag-mask. Make an airway management plan, including a backup approach, based on the clinical scenario. Gather equipment and medications. Necessary equipment is described in the text. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preoxygenation &ndash; We recommend that any patient who may require endotracheal intubation be given high flow oxygen immediately (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Preoxygenation creates an oxygen reservoir in the lungs, blood, and tissues that enables patients to tolerate a longer period of apnea without oxygen desaturation. The oxygen saturation of adults with severe illness or obesity, and pregnant women nearing the end of their third trimester, falls below 90 percent in less than three minutes, even if ideal preoxygenation is achieved. Time to desaturation in emergency practice is often more rapid than anticipated. Strategies to maximize preoxygenation are provided in the text. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Preoxygenation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pretreatment &ndash; Depending upon clinical circumstance and if time allows, specific medications may be given prior to the induction phase of RSI for the purpose of mitigating adverse effects associated with intubation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38775?source=see_link\">",
"       \"Pretreatment agents for rapid sequence intubation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Paralysis with induction &ndash; RSI involves the virtually simultaneous intravenous administration of a rapidly acting induction agent and a neuromuscular blocking agent (paralytic) aimed at producing a state of deep sedation and muscular relaxation quickly. Different induction agents are used depending on clinical circumstances (",
"      <a class=\"graphic graphic_table graphicRef64272 \" href=\"UTD.htm?35/29/36316\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=see_link\">",
"       \"Sedation or induction agents for rapid sequence intubation in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=see_link\">",
"       \"Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Protection and positioning &ndash; This step refers to protecting the airway prior to placement of the endotracheal tube by avoiding bag-mask ventilation. Bag-mask ventilation is unnecessary if the patient has been successfully preoxygenated. Ventilation interposed between paralysis and intubation creates a potential risk for regurgitation and aspiration. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Protection (cricoid pressure) and positioning'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Placement with proof &ndash; Once the intubation is performed, confirmation of proper endotracheal tube placement is crucial; unrecognized esophageal intubation leads to devastating complications. End-tidal CO2 determination (either colorimetric or quantitative) must be performed to determine proper placement. In cardiac arrest patients not producing CO2, alternative means of confirmation may be needed. A single-view chest x-ray is only useful to determine depth of placement; it cannot distinguish endotracheal from esophageal intubation. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Placement with proof'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Postintubation management &ndash; The endotracheal tube must be secured, a postintubation chest x-ray checked for evidence of complications, and appropriate ventilator management started. Drugs used for RSI are generally short-acting, and the clinician must provide adequate longer-term sedation, analgesia, and sometimes paralysis. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Postintubation management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/1\">",
"      Sagarin MJ, Barton ED, Chng YM, et al. Airway management by US and Canadian emergency medicine residents: a multicenter analysis of more than 6,000 endotracheal intubation attempts. Ann Emerg Med 2005; 46:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/2\">",
"      Li J, Murphy-Lavoie H, Bugas C, et al. Complications of emergency intubation with and without paralysis. Am J Emerg Med 1999; 17:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/3\">",
"      Sakles JC, Laurin EG, Rantapaa AA, Panacek EA. Airway management in the emergency department: a one-year study of 610 tracheal intubations. Ann Emerg Med 1998; 31:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/4\">",
"      Walls RM. Rapid-sequence intubation in head trauma. Ann Emerg Med 1993; 22:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/5\">",
"      Dronen SC, Merigian KS, Hedges JR, et al. A comparison of blind nasotracheal and succinylcholine-assisted intubation in the poisoned patient. Ann Emerg Med 1987; 16:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/6\">",
"      Bair AE, Filbin MR, Kulkarni RG, Walls RM. The failed intubation attempt in the emergency department: analysis of prevalence, rescue techniques, and personnel. J Emerg Med 2002; 23:131.",
"     </a>",
"    </li>",
"    <li>",
"     Walls, RM. Rapid Sequence Intubation. American College of Emergency Physicians Scientific Assembly, San Francisco, CA 1987.",
"    </li>",
"    <li>",
"     The mnemonics for difficult airway identification cited in this review are reproduced with permission from The Difficult Airway Course&trade;: Emergency.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/9\">",
"      Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med 2012; 59:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/10\">",
"      Lane S, Saunders D, Schofield A, et al. A prospective, randomised controlled trial comparing the efficacy of pre-oxygenation in the 20 degrees head-up vs supine position. Anaesthesia 2005; 60:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/11\">",
"      Ramkumar V, Umesh G, Philip FA. Preoxygenation with 20&ordm; head-up tilt provides longer duration of non-hypoxic apnea than conventional preoxygenation in non-obese healthy adults. J Anesth 2011; 25:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/12\">",
"      Boyce JR, Ness T, Castroman P, Gleysteen JJ. A preliminary study of the optimal anesthesia positioning for the morbidly obese patient. Obes Surg 2003; 13:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/13\">",
"      Ramachandran SK, Cosnowski A, Shanks A, Turner CR. Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. J Clin Anesth 2010; 22:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/14\">",
"      Taha SK, Siddik-Sayyid SM, El-Khatib MF, et al. Nasopharyngeal oxygen insufflation following pre-oxygenation using the four deep breath technique. Anaesthesia 2006; 61:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/15\">",
"      Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008; 107:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/16\">",
"      Baillard C, Fosse JP, Sebbane M, et al. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006; 174:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/17\">",
"      Herriger A, Frascarolo P, Spahn DR, Magnusson L. The effect of positive airway pressure during pre-oxygenation and induction of anaesthesia upon duration of non-hypoxic apnoea. Anaesthesia 2004; 59:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/18\">",
"      Mort TC, Waberski BH, Clive J. Extending the preoxygenation period from 4 to 8 mins in critically ill patients undergoing emergency intubation. Crit Care Med 2009; 37:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/19\">",
"      Pandit JJ, Duncan T, Robbins PA. Total oxygen uptake with two maximal breathing techniques and the tidal volume breathing technique: a physiologic study of preoxygenation. Anesthesiology 2003; 99:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/20\">",
"      Baraka A, Haroun-Bizri S, Khoury S, Chehab IR. Single vital capacity breath for preoxygenation. Can J Anaesth 2000; 47:1144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/21\">",
"      Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997; 87:979.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/22\">",
"      Ding ZN, Shibata K, Yamamoto K, et al. Decreased circulation time in the upper limb reduces the lag time of the finger pulse oximeter response. Can J Anaesth 1992; 39:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/23\">",
"      Ellis DY, Harris T, Zideman D. Cricoid pressure in emergency department rapid sequence tracheal intubations: a risk-benefit analysis. Ann Emerg Med 2007; 50:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/24\">",
"      Levitan RM, Kinkle WC, Levin WJ, Everett WW. Laryngeal view during laryngoscopy: a randomized trial comparing cricoid pressure, backward-upward-rightward pressure, and bimanual laryngoscopy. Ann Emerg Med 2006; 47:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/25\">",
"      Butler J, Sen A. Best evidence topic report. Cricoid pressure in emergency rapid sequence induction. Emerg Med J 2005; 22:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/26\">",
"      McNelis U, Syndercombe A, Harper I, Duggan J. The effect of cricoid pressure on intubation facilitated by the gum elastic bougie. Anaesthesia 2007; 62:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/27\">",
"      Oh J, Lim T, Chee Y, et al. Videographic analysis of glottic view with increasing cricoid pressure force. Ann Emerg Med 2013; 61:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/28\">",
"      Lovett PB, Flaxman A, St&uuml;rmann KM, Bijur P. The insecure airway: a comparison of knots and commercial devices for securing endotracheal tubes. BMC Emerg Med 2006; 6:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/29\">",
"      Clarke T, Evans S, Way P, et al. A comparison of two methods of securing an endotracheal tube. Aust Crit Care 1998; 11:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/30\">",
"      Kaplow R, Bookbinder M. A comparison of four endotracheal tube holders. Heart Lung 1994; 23:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/31\">",
"      Baraka AS, Taha SK, Aouad MT, et al. Preoxygenation: comparison of maximal breathing and tidal volume breathing techniques. Anesthesiology 1999; 91:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/32\">",
"      Ramez Salem M, Joseph NJ, Crystal GJ, et al. Preoxygenation: comparison of maximal breathing and tidal volume techniques. Anesthesiology 2000; 92:1845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/33\">",
"      Koh KF, Chen FG. Rapid tracheal intubation with atracurium: the timing principle. Can J Anaesth 1994; 41:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/34\">",
"      Culling RD, Middaugh RE, Menk EJ. Rapid tracheal intubation with vecuronium: the timing principle. J Clin Anesth 1989; 1:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1912/abstract/35\">",
"      Silverman SM, Culling RD, Middaugh RE. Rapid-sequence orotracheal intubation: a comparison of three techniques. Anesthesiology 1990; 73:244.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 270 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-CDD449C725-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1912=[""].join("\n");
var outline_f1_55_1912=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DESCRIPTION OF THE TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Preoxygenation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Pretreatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Paralysis with induction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Induction agents",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Neuromuscular blocking agents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Protection (cricoid pressure) and positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Placement with proof",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Postintubation management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      VARIATIONS OF TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Accelerated sequence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Timing principle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/270\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/270|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/58/2976\" title=\"figure 1\">",
"      Time to oxygen desaturation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/53/22354\" title=\"figure 2\">",
"      Sellick maneuver",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/270|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?12/11/12475\" title=\"table 1\">",
"      Rapid sequence intubation seven Ps timing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/44/26315\" title=\"table 2\">",
"      Mnemonic for tracheal intubation preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/29/36316\" title=\"table 3\">",
"      Rapid sequence intubation induction agents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23079?source=related_link\">",
"      Basic airway management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/14/28906?source=related_link\">",
"      Direct laryngoscopy and tracheal intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/54/20329?source=related_link\">",
"      Emergency airway management in the morbidly obese patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/25/6554?source=related_link\">",
"      Mechanical ventilation of adults in the emergency department",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31288?source=related_link\">",
"      Neuromuscular blocking agents (NMBA) for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/55/38775?source=related_link\">",
"      Pretreatment agents for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/29/24026?source=related_link\">",
"      Rapid sequence intubation (RSI) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/30/11754?source=related_link\">",
"      Sedation or induction agents for rapid sequence intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/12/22726?source=related_link\">",
"      The decision to intubate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/7/18552?source=related_link\">",
"      The difficult airway in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13639?source=related_link\">",
"      Treatment of severe hypovolemia or hypovolemic shock in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/35/40505?source=related_link\">",
"      Use of vasopressors and inotropes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_55_1913="Cholinesterase inhibitors in the treatment of dementia";
var content_f1_55_1913=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cholinesterase inhibitors in the treatment of dementia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Daniel Press, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Michael Alexander, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Kenneth E Schmader, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1913/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1913/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/55/1913/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with Alzheimer disease (AD) have reduced cerebral production of choline acetyl transferase, which leads to a decrease in acetylcholine synthesis and impaired cortical cholinergic function. This early discovery of a marked cholinergic deficit in the brains of patients with AD led to the study of therapeutically augmenting cholinergic activity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/1\">",
"     1",
"    </a>",
"    ]. However, acetylcholine precursors were found to be ineffective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], while postsynaptic cholinergic receptor agonists had unacceptable side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/4\">",
"     4",
"    </a>",
"    ]. By contrast, the results of studies with cholinesterase inhibitors, which increase cholinergic transmission by inhibiting cholinesterase at the synaptic cleft, have been more encouraging, and these drugs may even have some utility in the non-AD dementias.",
"   </p>",
"   <p>",
"    This topic will discuss the use of cholinesterase inhibitors in the treatment of dementia. Other treatments of dementia are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"     \"Treatment of dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ALZHEIMER DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Four cholinesterase inhibitors, tacrine,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    are currently approved for use in Alzheimer disease (AD) by the US Food and Drug Administration (FDA). Tacrine was the first agent approved for use in AD, but it can cause hepatotoxicity and is rarely used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/5\">",
"     5",
"    </a>",
"    ]. The choice between the other three agents is largely based upon cost, individual patient tolerability, and physician experience, as efficacy appears to be similar (",
"    <a class=\"graphic graphic_table graphicRef63284 \" href=\"UTD.htm?31/57/32667\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Donepezil",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     Donepezil",
"    </a>",
"    has relatively little peripheral anticholinesterase activity and is generally well tolerated. This combined with its once-daily dosing has made it a popular drug in patients with AD. The recommended dose for donepezil is 5 mg per day for 4 weeks, then increasing to 10 mg per day. Donepezil is available in pill form and also as an oral disintegrating tablet.",
"   </p>",
"   <p>",
"    The efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    was demonstrated in a 24-week double-blind study in which patients with mild to moderate AD were randomly assigned to donepezil (5 or 10",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    or placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/9\">",
"     9",
"    </a>",
"    ]. Cognition, as measured by the Alzheimer Disease Assessment Scale, cognitive subscale (ADAS-cog) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/10\">",
"     10",
"    </a>",
"    ], and the Clinician's global ratings were significantly improved in both treatment groups compared with placebo. There was no consistent effect noted on patient-related quality of life measures.",
"   </p>",
"   <p>",
"    A second placebo-controlled trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    (AD2000) enrolled 566 patients referred to memory clinics with mild to moderate AD, with or without cerebrovascular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"     11",
"    </a>",
"    ]. There was a small but significant beneficial effect of donepezil for cognition compared with placebo, with a 0.8 point difference in the Mini Mental Status Exam (MMSE) score (95% CI 0.5-1.2) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"     11",
"    </a>",
"    ]. This size effect of cognitive improvement was similar to that seen in other randomized trials of donepezil [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/12\">",
"     12",
"    </a>",
"    ]. Although donepezil slowed the decline in activities of daily living in patients with moderate to severe AD in an earlier study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/13\">",
"     13",
"    </a>",
"    ], it did not delay entry to institutional care in the AD2000 study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A six-week placebo washout was performed after 24 weeks of the study cited above to examine whether",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    had any disease-modifying activity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/9\">",
"     9",
"    </a>",
"    ]. The improvements on cognitive measures were erased, strongly suggesting that the drug does not affect the underlying course of disease.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     Donepezil",
"    </a>",
"    may also have benefit for patients who have crossed the threshold from mild cognitive impairment (MCI) to early stage AD, but the data are limited. One trial enrolled 153 patients with early-stage AD (MMSE scores of 21 to 26 and only mild impairment on activities of normal living) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/14\">",
"     14",
"    </a>",
"    ]. Donepezil treatment was associated with a significant, but clinically modest, 2.3 point improvement on the ADAS-cog at 24 weeks compared with placebo.",
"   </p>",
"   <p>",
"    The potential benefits of a higher dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    were evaluated in a randomized trial that compared daily doses of 10 and 23 mg in 1371 patients with moderate to severe AD who had been treated with 10 mg donepezil for at least three months [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/15\">",
"     15",
"    </a>",
"    ]. After 24 weeks, some benefits of cognition were seen in the higher dose group, but there were no significant differences in global functioning. Treatment emergent adverse effects were more frequent in the higher dose group.",
"   </p>",
"   <p>",
"    In general, prolonged treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    appears to be safe and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. Cholinergic side effects (primarily diarrhea, nausea, and vomiting) are transient and generally mild, occurring in about 20 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/9\">",
"     9",
"    </a>",
"    ]. Symptomatic bradycardia is another potential adverse effect [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. In one population-based cohort, the incidence of hospitalization for syncope was 3.2 events per 100 person years for individuals taking cholinesterase inhibitors (68 percent were taking donepezil) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/20\">",
"     20",
"    </a>",
"    ]. This event rate was 1.7 times higher than in a control group.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     Donepezil",
"    </a>",
"    and other cholinesterase inhibitors appear to modestly improve neuropsychiatric symptoms as well. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=see_link&amp;anchor=H18#H18\">",
"     \"Treatment of behavioral symptoms related to dementia\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Rivastigmine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     Rivastigmine",
"    </a>",
"    appears to be beneficial in patients with mild to moderate AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/21\">",
"     21",
"    </a>",
"    ] and has been approved for use by the FDA. Its side effect profile is related to cholinergic effects, with significant nausea, vomiting, anorexia, and headaches. It should be given with food to minimize nausea. One case of esophageal rupture due to severe vomiting has been reported; the manufacturer advises slow titration of the drug (eg, initiating therapy at 1.5 mg twice daily with titration every two weeks up to 6 mg twice daily) and, if treatment is interrupted for longer than several days, it should be restarted at the lowest daily dose and then titrated again [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/22\">",
"     22",
"    </a>",
"    ]. While not compared head-to-head with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    , its efficacy appears similar, although it may have more gastrointestinal side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One double-blind, placebo-controlled study found that side effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    may be ameliorated and higher daily doses achieved (9.6 versus 8.9 mg), when it is given three times a day, rather than twice daily [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A transdermal patch formulation of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    has been approved by the FDA. In 1195 patients with AD, a 10 cm2 patch (9.5 mg per 24 hours) appeared to have similar efficacy with significantly less nausea and vomiting compared to the highest oral dose (6 mg twice daily) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/25\">",
"     25",
"    </a>",
"    ]. The higher dose patch (20 cm2) was associated with greater cognitive improvement compared to the lower dose patch on one of two primary outcome measures (ADAS-cog) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Galantamine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     Galantamine",
"    </a>",
"    (Razadyne; previously marketed as Reminyl) appears to be effective in patients with mild to moderate AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/27\">",
"     27",
"    </a>",
"    ]. Randomized controlled trials have found that treatment with galantamine (maintenance dose 24 or 32",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    slowed the decline in both cognition and activities of daily living compared with placebo in patients with early AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/28-31\">",
"     28-31",
"    </a>",
"    ]. Cognitive benefits of galantamine have been sustained for up to 36 months [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/32\">",
"     32",
"    </a>",
"    ]. A secondary analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/33\">",
"     33",
"    </a>",
"    ] of a randomized controlled trial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/29\">",
"     29",
"    </a>",
"    ] reported that galantamine-treated AD patients had significantly better overall ADL scores than the placebo group at five months regardless of dementia severity.",
"   </p>",
"   <p>",
"    Gastrointestinal symptoms (nausea, vomiting, diarrhea, anorexia, weight loss) are the most common adverse effects of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    . Like",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    , galantamine appears to have similar efficacy to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    in patients with AD but may have more gastrointestinal side effects.",
"   </p>",
"   <p>",
"    The use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    has been associated with increased mortality in patients with MCI [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=see_link&amp;anchor=H15#H15\">",
"     \"Mild cognitive impairment: Prognosis and treatment\", section on 'Acetylcholinesterase inhibitors'",
"    </a>",
"    .) Increased mortality has not been observed in patients treated for AD, mixed dementia, or vascular dementia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Advanced disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although efficacy of cholinesterase inhibitors for cognitive effects has been established in patients with mild to moderate AD, it has been less certain that patients with advanced AD, including patients in nursing homes, will benefit from therapy. Five placebo-controlled trials of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    and one of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    in patients with advanced AD have been reported. Differences in these studies include: the study population (nursing home versus community dwellers), the severity of dementia among trial participants, and the outcomes measured:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 290 patients living at home or in assisted living with baseline MMSE of 5 to 17, 24 weeks of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      treatment was associated with improvements on all primary and secondary outcome measures including the Clinician's Interview-based Impression of Change, MMSE, Severe Impairment battery, Functional rating scale, Disability assessment, and Neuropsychiatric inventory [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      In 208 nursing home residents, 70 percent of whom had a MMSE score &lt;20 at baseline,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      was associated with improved clinical dementia rating (CDR) and MMSE scores at six months compared with placebo-treated patients, who declined [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/36\">",
"       36",
"      </a>",
"      ]. However, there was no difference between groups in the primary outcome measure of the Neuropsychiatric inventory.",
"     </li>",
"     <li>",
"      In 216 nursing home residents with severe AD (MMSE score of 1 to 10),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      -treated patients showed improved cognitive ability on a Severe Impairment Battery, while placebo-treated patients worsened [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/37\">",
"       37",
"      </a>",
"      ]. Treatment was also associated with less severe decline in activities of daily living.",
"     </li>",
"     <li>",
"      In 243 community-dwelling patients with severe AD (MMSE score 1 to 12), those who were assigned to",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      treatment improved on a number of cognitive and functional measures (Severe Impairment Battery, Clinician's Interview-based Impression of Change, and MMSE), but not on others (activities of daily living, neuropsychiatric inventory, caregiver burden, resource utilization) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A clinical trial of 295 patients with moderate to severe AD who were already taking",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      compared the efficacy of four treatment strategies: no therapy (donepezil discontinued), donepezil continued alone, donepezil continued with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"       memantine",
"      </a>",
"      added, and memantine therapy alone [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/39\">",
"       39",
"      </a>",
"      ]. After one year, patients assigned to receive donepezil therapy had, on average, a higher score on the standardized MMSE (1.9 points) and a lower score on the Bristol Activities of Daily Living Scale (3.0 points), both results implying benefit, compared to those not receiving donepezil. The average differences in score on the MMSE, but not the BADLS, met the prespecified threshold considered by the investigators to be clinically important. The trial was stopped early due to slow recruitment.",
"     </li>",
"     <li>",
"      In 407 nursing home residents with severe AD (MMSE score 5 to 12), treatment with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"       galantamine",
"      </a>",
"      was associated with improved scores on a severe impairment battery and less severe worsening on an activities of daily living scale [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With all studies showing a similar incidence of adverse events in both treatment groups,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    appears safe and well tolerated in patients with advanced AD. Patients on donepezil were more likely to experience gastrointestinal side effects and to discontinue treatment than patients on placebo.",
"   </p>",
"   <p>",
"    Based upon these results, a trial of cholinesterase inhibitors in patients with advanced Alzheimer disease is reasonable. Decisions on long-term use depend on the patient's functional response to treatment and long-term goals of care, and should be made in consultation with caregivers and family [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     OTHER DEMENTIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some controversy exists over who should be treated with cholinesterase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/41,42\">",
"     41,42",
"    </a>",
"    ]. Nonetheless, these medications appear to offer similar or greater benefits for certain non-Alzheimer dementias such as vascular dementia (VaD) and dementia with Lewy bodies (DLB), and perhaps for dementia or cognitive impairment associated with Parkinson disease (PD).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Vascular dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with VaD have shown improvement in cognition, behavior, and activities of daily living with cholinesterase inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/43\">",
"     43",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10104?source=see_link\">",
"     \"Treatment and prevention of vascular dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Mixed dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mixed dementia denotes a condition with clinical and pathological features of both Alzheimer disease (AD) and VaD. A systematic review of the literature published in 2004 concluded that cholinesterase inhibitors provide modest clinical benefits for patients with mixed dementia; the benefit is similar in magnitude to that found for cholinesterase inhibitor treatment of AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/44\">",
"     44",
"    </a>",
"    ]. Only two trials, one of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"     galantamine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/45\">",
"     45",
"    </a>",
"    ] and the other of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/46\">",
"     46",
"    </a>",
"    ], evaluated patients with mixed dementia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Dementia with Lewy bodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who have dementia with DLB can have marked improvements in cognition as well as improvements in behavioral symptoms and hallucinations, warranting a trial of cholinesterase inhibitors whenever this diagnosis is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link\">",
"     \"Prognosis and treatment of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Parkinson disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with PD, the prevalence of dementia is quite high. Studies suggest that cholinesterase inhibitors have modest benefits in patients who have dementia associated with PD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. In our experience, a subset of patients show marked improvement with these medications. Because of this and the fact that cholinesterase inhibitors can alleviate visual hallucinations, we suggest a treatment trial in this patient population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19220244\">",
"    <span class=\"h2\">",
"     Frontotemporal dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The available data do not support the use of cholinesterase inhibitors in FTD. However, a treatment trial is not unreasonable when there is uncertainty as to the underlying diagnosis (AD versus FTD). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/25/408?source=see_link&amp;anchor=H9729354#H9729354\">",
"     \"Frontotemporal dementia: Treatment\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Mild cognitive impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the aggregate, trials have not provided support for the use of cholinesterase inhibitors in preventing progression of mild cognitive impairment to dementia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=see_link&amp;anchor=H15#H15\">",
"     \"Mild cognitive impairment: Prognosis and treatment\", section on 'Acetylcholinesterase inhibitors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Huntington disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is currently no evidence that supports the use of cholinesterase inhibitors in patients with Huntington disease. A double-blind, randomized trial of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    10 mg daily in 24 patients with Huntington disease demonstrated no difference between treatment and placebo on measures of cognition, chorea, or quality of life after 12 weeks of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Traumatic brain injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Animal studies have suggested potential efficacy for cholinesterase inhibitors in patients with cognitive impairment resulting from traumatic brain injury (TBI). However, in a 12-week trial of 157 patients one year after TBI, measures of cognitive improvement were no different in the patients randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"     rivastigmine",
"    </a>",
"    versus those receiving placebo [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/53\">",
"     53",
"    </a>",
"    ]. Subgroup analysis in this small trial suggested significant benefit for rivastigmine in patients with moderate to severe memory impairment. This finding requires independent confirmation before cholinesterase inhibitors can be recommended for these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19220311\">",
"    <span class=\"h2\">",
"     Multiple sclerosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive impairment is not uncommon in multiple sclerosis although frank dementia is. Studies on the efficacy of cholinesterase inhibitors in MS have had mixed results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36985?source=see_link&amp;anchor=H6#H6\">",
"     \"Comorbid problems associated with multiple sclerosis in adults\", section on 'Cholinesterase inhibitors'",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PRACTICE ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Degree of benefit",
"    </span>",
"    &nbsp;&mdash;&nbsp;The average benefit of cholinesterase inhibitors in patients with dementia is a small improvement in cognition and activities of daily living [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/43,48,54-57\">",
"     43,48,54-57",
"    </a>",
"    ]. Whether these drugs significantly improve long-term outcomes, such as the need for nursing home admission or maintaining critical activities of daily living (ADLs), remains in doubt, and the evidence is conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/6,11,42,58\">",
"     6,11,42,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis of 29 randomized, placebo-controlled trials completed through December 2001, patients on cholinesterase inhibitors improved 0.1 SDs on ADL scales and 0.09 SDs on instrumental ADL (IADL) scales compared with placebo, an effect that would be similar to preventing a two months per year decline in a typical patient with Alzheimer disease (AD) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A second meta-analysis concluded that 12 patients would need to be treated for one to benefit by achieving minimal improvement or better [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/59\">",
"       59",
"      </a>",
"      ]. Treating 12 patients would also result in one additional patient having a treatment-related adverse event (mostly gastrointestinal side effects). Similar benefits are seen with cholinesterase inhibitors in patients with vascular dementia (VaD) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/43,54,55\">",
"       43,54,55",
"      </a>",
"      ], and cholinesterase inhibitors appear to show greater efficacy in patients with diffuse Lewy body dementia [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A 2008 systematic review concluded that improvements in cognitive measures and global assessment of dementia associated with the use of cholinesterase inhibitors were clinically marginal, despite being statistically significant [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The AD2000 study, the only nonpharmaceutical industry sponsored trial of cholinesterase inhibitors, found no significant benefit of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      compared with placebo for the two primary endpoints: entry to institutional care and progression of disability [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Additional evidence suggests that the response to cholinesterase inhibitors may be quite variable, with as many as 30 to 50 percent of patients showing no observable benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/60,61\">",
"     60,61",
"    </a>",
"    ], while a smaller proportion (up to 20 percent) may show a greater than average response (&ge;7 point ADAS-cog improvement) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/44,62\">",
"     44,62",
"    </a>",
"    ]. These findings reinforce the importance of making individualized decisions for each patient based on clinical response and side-effects.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since cholinesterase inhibitors are a symptomatic treatment and not disease-modifying, we generally administer them for eight weeks at the recommended or maximum tolerated dose and then review the patient's response with the family. Treatment is continued if improvement is noted either on bedside testing or by the family. We stop treatment at this point if there has been no improvement. The Mini Mental Status Exam (MMSE) is not specific enough for following response; we generally use a combination of naming, recall at 30 seconds and five minutes of a four-word list, and semantic fluency (eg, naming as many animals as possible in one minute).",
"   </p>",
"   <p>",
"    Occasionally patients will worsen after stopping therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. It is not clear if this is a sign that they benefited from the medication, but we generally reintroduce it when clinical decline is closely temporally linked with medication withdrawal. While data from clinical trials suggested that treatment gaps (periods in which the patient did not take cholinesterase inhibitor) were associated with worse outcomes, a large observational study of elderly patients prescribed cholinesterase inhibitors found that the risk of institutionalization or death did not appear to be increased among those who experienced treatment gaps [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cholinesterase inhibitors can be continued indefinitely. However, while there may be a clinical benefit in patients with moderately advanced disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/35,36\">",
"     35,36",
"    </a>",
"    ], we generally discontinue the medication when a patient progresses to advanced dementia (tapering over a 2 to 3 week period), and only reintroduce it if there is any deterioration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Cost-effectiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early analyses suggested that the cost of cholinesterase inhibitors might be partially or even completely offset by lower home care costs and delayed nursing home placement [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/66-69\">",
"     66-69",
"    </a>",
"    ]. However, these findings were based upon a number of favorable assumptions, including factors such as the duration of drug effect and delayed nursing home placement, for which controlled data were lacking. Furthermore, the AD2000 study discussed above found no benefit for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"     donepezil",
"    </a>",
"    compared with placebo for entry to institutional care or formal care costs [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?31/22/32098?source=see_link\">",
"       \"Patient information: Tips for caregivers of people with Alzheimer disease (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following recommendations are based upon our clinical practice given the existing evidence on therapies for dementia:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest a treatment trial with a cholinesterase inhibitor for patients with mild to moderate dementia (MMSE 10 to 26) (",
"      <a class=\"grade\" href=\"._grade_4?title=Grade 2A\">",
"       Grade 2A",
"      </a>",
"      ). The choice between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/30/10726?source=see_link\">",
"       donepezil",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/26/6567?source=see_link\">",
"       rivastigmine",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/27/6582?source=see_link\">",
"       galantamine",
"      </a>",
"      can be based upon cost, individual patient tolerance, and physician experience, as efficacy appears to be similar (",
"      <a class=\"graphic graphic_table graphicRef63284 \" href=\"UTD.htm?31/57/32667\">",
"       table 1",
"      </a>",
"      ). Because of associated hepatotoxicity, we do not routinely use tacrine (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Cholinesterase inhibitors in patients with dementia produce, on average, small improvements in measures of cognition and activities of daily living (ADL). Not all patients benefit. Their impact on long-term outcomes, disability and institutionalization, is not clear. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Degree of benefit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although most studies of cholinesterase inhibitors have been in patients with Alzheimer disease (AD), there is some evidence of benefit for patients with vascular dementia (VaD), mixed dementia, dementia with Lewy bodies (DLB), and dementia in Parkinson disease (PD). We suggest a treatment trial of a cholinesterase inhibitor in these patients as well. (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Other dementias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with dementia may also benefit from",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/16/24837?source=see_link\">",
"       memantine",
"      </a>",
"      and other therapies. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=see_link\">",
"       \"Treatment of dementia\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In patients with severe dementia, cholinesterase inhibitors can be tapered off over a two to four week period, but they should be restarted if the patient worsens without the medication (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Duration of therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not routinely recommend cholinesterase inhibitors for patients with mild cognitive impairment (MCI), but if memory problems are particularly troubling to the patient, then a trial for symptomatic benefit may be warranted (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=see_link&amp;anchor=H15#H15\">",
"       \"Mild cognitive impairment: Prognosis and treatment\", section on 'Acetylcholinesterase inhibitors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/1\">",
"      Whitehouse PJ, Price DL, Struble RG, et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982; 215:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/2\">",
"      Etienne P, Dastoor D, Gauthier S, et al. Alzheimer disease: lack of effect of lecithin treatment for 3 months. Neurology 1981; 31:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/3\">",
"      Thal LJ, Rosen W, Sharpless NS, Crystal H. Choline chloride fails to improve cognition of Alzheimer's disease. Neurobiol Aging 1981; 2:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/4\">",
"      Bodick NC, Offen WW, Levey AI, et al. Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol 1997; 54:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/5\">",
"      Watkins PB, Zimmerman HJ, Knapp MJ, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994; 271:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/6\">",
"      Trinh NH, Hoblyn J, Mohanty S, Yaffe K. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA 2003; 289:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/7\">",
"      Raina P, Santaguida P, Ismaila A, et al. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline. Ann Intern Med 2008; 148:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/8\">",
"      Qaseem A, Snow V, Cross JT Jr, et al. Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med 2008; 148:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/9\">",
"      Rogers SL, Farlow MR, Doody RS, et al. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998; 50:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/10\">",
"      Weyer G, Erzigkeit H, Kanowski S, et al. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int Psychogeriatr 1997; 9:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/11\">",
"      Courtney C, Farrell D, Gray R, et al. Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial. Lancet 2004; 363:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/12\">",
"      Birks JS, Harvey R. Donepezil for dementia due to Alzheimer's disease. Cochrane Database Syst Rev 2003; :CD001190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/13\">",
"      Feldman H, Gauthier S, Hecker J, et al. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc 2003; 51:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/14\">",
"      Seltzer B, Zolnouni P, Nunez M, et al. Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 2004; 61:1852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/15\">",
"      Farlow MR, Salloway S, Tariot PN, et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study. Clin Ther 2010; 32:1234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/16\">",
"      Doody RS, Geldmacher DS, Gordon B, et al. Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease. Arch Neurol 2001; 58:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/17\">",
"      Mohs RC, Doody RS, Morris JC, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology 2001; 57:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/18\">",
"      Winblad B, Engedal K, Soininen H, et al. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 2001; 57:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/19\">",
"      Hernandez RK, Farwell W, Cantor MD, Lawler EV. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. J Am Geriatr Soc 2009; 57:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/20\">",
"      Gill SS, Anderson GM, Fischer HD, et al. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med 2009; 169:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/21\">",
"      Birks J, Grimley Evans J, Iakovidou V, et al. Rivastigmine for Alzheimer's disease. Cochrane Database Syst Rev 2009; :CD001191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/22\">",
"      Novartis Exelon labeling update reflects report of esophageal rupture. The Pink Sheet 2001; 63:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/23\">",
"      R&ouml;sler M, Anand R, Cicin-Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ 1999; 318:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/24\">",
"      Feldman HH, Lane R, Study 304 Group. Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2007; 78:1056.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/25\">",
"      Winblad B, Cummings J, Andreasen N, et al. A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule. Int J Geriatr Psychiatry 2007; 22:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/26\">",
"      Winblad B, Grossberg G, Fr&ouml;lich L, et al. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease. Neurology 2007; 69:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/27\">",
"      Olin J, Schneider L. Galantamine for Alzheimer's disease. Cochrane Database Syst Rev 2001; :CD001747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/28\">",
"      Wilcock GK, Lilienfeld S, Gaens E. Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group. BMJ 2000; 321:1445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/29\">",
"      Tariot PN, Solomon PR, Morris JC, et al. A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group. Neurology 2000; 54:2269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/30\">",
"      Rockwood K, Mintzer J, Truyen L, et al. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial. J Neurol Neurosurg Psychiatry 2001; 71:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/31\">",
"      Rockwood K, Fay S, Song X, et al. Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial. CMAJ 2006; 174:1099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/32\">",
"      Raskind MA, Peskind ER, Truyen L, et al. The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial. Arch Neurol 2004; 61:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/33\">",
"      Galasko D, Kershaw PR, Schneider L, et al. Galantamine maintains ability to perform activities of daily living in patients with Alzheimer's disease. J Am Geriatr Soc 2004; 52:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/34\">",
"      Mayor S. Regulatory authorities review use of galantamine in mild cognitive impairment. BMJ 2005; 330:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/35\">",
"      Feldman H, Gauthier S, Hecker J, et al. A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology 2001; 57:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/36\">",
"      Tariot PN, Cummings JL, Katz IR, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. J Am Geriatr Soc 2001; 49:1590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/37\">",
"      Winblad B, Kilander L, Eriksson S, et al. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 2006; 367:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/38\">",
"      Black SE, Doody R, Li H, et al. Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology 2007; 69:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/39\">",
"      Howard R, McShane R, Lindesay J, et al. Donepezil and memantine for moderate-to-severe Alzheimer's disease. N Engl J Med 2012; 366:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/40\">",
"      Burns A, Bernabei R, Bullock R, et al. Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial. Lancet Neurol 2009; 8:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/41\">",
"      Sandson TA. Metrifonate for Alzheimer's disease: is the next cholinesterase inhibitor better? Neurology 1999; 52:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/42\">",
"      Schneider LS. AD2000: donepezil in Alzheimer's disease. Lancet 2004; 363:2100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/43\">",
"      Erkinjuntti T, Rom&aacute;n G, Gauthier S, et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004; 35:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/44\">",
"      Langa KM, Foster NL, Larson EB. Mixed dementia: emerging concepts and therapeutic implications. JAMA 2004; 292:2901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/45\">",
"      Erkinjuntti T, Kurz A, Gauthier S, et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet 2002; 359:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/46\">",
"      Kumar V, Anand R, Messina J, et al. An efficacy and safety analysis of Exelon in Alzheimer's disease patients with concurrent vascular risk factors. Eur J Neurol 2000; 7:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/47\">",
"      McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet 2000; 356:2031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/48\">",
"      Aarsland D, Laake K, Larsen JP, Janvin C. Donepezil for cognitive impairment in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2002; 72:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/49\">",
"      Ravina B, Putt M, Siderowf A, et al. Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 2005; 76:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/50\">",
"      Emre M, Aarsland D, Albanese A, et al. Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 2004; 351:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/51\">",
"      Wesnes KA, McKeith I, Edgar C, et al. Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 2005; 65:1654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/52\">",
"      Cubo E, Shannon KM, Tracy D, et al. Effect of donepezil on motor and cognitive function in Huntington disease. Neurology 2006; 67:1268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/53\">",
"      Silver JM, Koumaras B, Chen M, et al. Effects of rivastigmine on cognitive function in patients with traumatic brain injury. Neurology 2006; 67:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/54\">",
"      Wilkinson D, Doody R, Helme R, et al. Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology 2003; 61:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/55\">",
"      Black S, Rom&aacute;n GC, Geldmacher DS, et al. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003; 34:2323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/56\">",
"      Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001; 56:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/57\">",
"      Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP, van den Bussche H. Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials. BMJ 2005; 331:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/58\">",
"      Lopez OL, Becker JT, Wisniewski S, et al. Cholinesterase inhibitor treatment alters the natural history of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2002; 72:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/59\">",
"      Lanct&ocirc;t KL, Herrmann N, Yau KK, et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis. CMAJ 2003; 169:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/60\">",
"      Cummings JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry 2003; 11:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/61\">",
"      Clark CM, Karlawish JH. Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med 2003; 138:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/62\">",
"      Grossberg GT, Desai AK. Management of Alzheimer's disease. J Gerontol A Biol Sci Med Sci 2003; 58:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/63\">",
"      Holmes C, Wilkinson D, Dean C, et al. The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease. Neurology 2004; 63:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/64\">",
"      Rainer M, Mucke HA, Kr&uuml;ger-Rainer C, et al. Cognitive relapse after discontinuation of drug therapy in Alzheimer's disease: cholinesterase inhibitors versus nootropics. J Neural Transm 2001; 108:1327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/65\">",
"      Pariente A, Fourrier-R&eacute;glat A, Bazin F, et al. Effect of treatment gaps in elderly patients with dementia treated with cholinesterase inhibitors. Neurology 2012; 78:957.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/66\">",
"      Lubeck DP, Mazonson PD, Bowe T. Potential effect of tacrine on expenditures for Alzheimer's disease. Med Interface 1994; 7:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/67\">",
"      Henke CJ, Burchmore MJ. The economic impact of the tacrine in the treatment of Alzheimer's disease. Clin Ther 1997; 19:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/68\">",
"      Neumann PJ, Hermann RC, Kuntz KM, et al. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease. Neurology 1999; 52:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1913/abstract/69\">",
"      Hauber AB, Gnanasakthy A, Mauskopf JA. Savings in the cost of caring for patients with Alzheimer's disease in Canada: an analysis of treatment with rivastigmine. Clin Ther 2000; 22:439.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5072 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-3C09538E6E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1913=[""].join("\n");
var outline_f1_55_1913=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ALZHEIMER DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Donepezil",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Rivastigmine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Galantamine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Advanced disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      OTHER DEMENTIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Mixed dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19220244\">",
"      Frontotemporal dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Mild cognitive impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Huntington disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19220311\">",
"      Multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PRACTICE ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Degree of benefit",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Cost-effectiveness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5072\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5072|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/57/32667\" title=\"table 1\">",
"      Cholinesterase inhibitors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/7/36985?source=related_link\">",
"      Comorbid problems associated with multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/25/408?source=related_link\">",
"      Frontotemporal dementia: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/33/26138?source=related_link\">",
"      Mild cognitive impairment: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=related_link\">",
"      Parkinson disease dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/14/31970?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?31/22/32098?source=related_link\">",
"      Patient information: Tips for caregivers of people with Alzheimer disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=related_link\">",
"      Prognosis and treatment of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/55/10104?source=related_link\">",
"      Treatment and prevention of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/48/27402?source=related_link\">",
"      Treatment of behavioral symptoms related to dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33865?source=related_link\">",
"      Treatment of dementia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_55_1914="Clinical features and diagnosis of dementia with Lewy bodies";
var content_f1_55_1914=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of dementia with Lewy bodies",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Ann Marie Hake, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Martin R Farlow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Steven T DeKosky, MD, FAAN",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/55/1914/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/55/1914/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia with Lewy bodies (DLB) is increasingly recognized clinically as the second most common type of degenerative dementia after Alzheimer disease (AD). In addition to dementia, distinctive clinical features include: visual hallucinations, parkinsonism, cognitive fluctuations, dysautonomia, sleep disorders, and neuroleptic sensitivity.",
"   </p>",
"   <p>",
"    First described in the 1960s, DLB has a varied clinical presentation that shares features with other degenerative dementias. It was often overlooked pathologically because of the difficulty in identifying cortical Lewy bodies. With the advent of immunohistochemical stains for some of the constituents of Lewy bodies, the prevalence of this disorder began to be recognized. However, challenges remain in defining this as a distinct entity differentiable from other degenerative dementias.",
"   </p>",
"   <p>",
"    There is some clinical imperative to diagnose DLB, as optimal treatment choices - for best efficacy and limitation of significant side effects - are specific to DLB. However, DLB continues to be under recognized, and the clinical diagnostic criteria continue to be refined to improve specificity and sensitivity.",
"   </p>",
"   <p>",
"    This topic will describe the clinical and radiologic features and diagnosis of dementia with Lewy bodies. The epidemiology, neuropathology, pathogenesis, prognosis, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=see_link\">",
"     \"Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link\">",
"     \"Prognosis and treatment of dementia with Lewy bodies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other dementia syndromes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27162?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Alzheimer disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=see_link\">",
"     \"Frontotemporal dementia: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consensus criteria for the diagnosis of Dementia with Lewy bodies (DLB) were developed by the Consortium on Dementia with Lewy Bodies and have been successively revised to improve sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/1\">",
"     1",
"    </a>",
"    ]. The Table outlines the clinical diagnostic criteria for probable and possible DLB defined by the third report of the DLB consortium (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ). Dementia is essential to the diagnosis of DLB. Other clinical manifestations of DLB are organized into a hierarchy of diagnostic specificity of core, suggestive, and supportive features.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cognitive dysfunction is often the presenting symptom in DLB, and dementia eventually occurs in all cases. Unlike Alzheimer disease (AD), which typically presents with memory loss as its first and most prominent cognitive deficit, DLB is characterized by early impairments in attention and executive and visuospatial function, with memory affected later in the course of the disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/2-8\">",
"     2-8",
"    </a>",
"    ]. Early symptoms include driving difficulty (eg, getting lost, misjudging distances, or failing to see stop signs or other cars) and impaired job performance.",
"   </p>",
"   <p>",
"    Bedside tests of cognitive function, eg, the Mini-Mental State Examination (MMSE) are not reliable to differentiate among dementia types. However, the early appearance of impaired figure copying (overlapping pentagons), clock drawing, and serial sevens (or spelling WORLD backward) is suggestive of DLB, while AD patients generally show impaired short-term memory and orientation as the earliest deficits on the MMSE [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In one study with neuropathologic confirmation, absence of visuospatial impairments in the early stages of disease helped to exclude DLB with a negative predictive value of 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early signs on neuropsychological testing may include deficiencies in tests of visuospatial and visuo-perception [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/4,8,11,12\">",
"     4,8,11,12",
"    </a>",
"    ]. Measures of executive function and attention (eg, Trail-Making Test, Wisconsin Card-Sorting Test, letter and category verbal fluency tests) may also be impaired early on [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/13\">",
"     13",
"    </a>",
"    ]. When memory does become impaired in DLB, memory retrieval may be more affected than acquisition [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/14\">",
"     14",
"    </a>",
"    ]. Neuropsychological tests, while helpful in quantifying and qualifying neurologic deficits, do not have clear discriminative ability for different dementia syndromes.",
"   </p>",
"   <p>",
"    DLB patients with prominent AD pathology (eg, neurofibrillary tangles) may have a cognitive profile that is more characteristic of AD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Core clinical features",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to dementia, a patient with probable DLB must have at least two of three of the so-called \"core clinical features\" of DLB: cognitive fluctuations, visual hallucinations, and parkinsonism (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Fluctuations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluctuations in cognition and levels of alertness may occur early in the course of DLB and are estimated to be a feature in 60 to 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/15\">",
"     15",
"    </a>",
"    ] of cases. The severity, duration, and type of symptoms involved in fluctuations is quite varied, even for a given patient. Episodes can be subtle, as in a brief decline in ability to perform an activity of daily living, or they may be dramatic enough to raise the question of a stroke or seizure. Caregivers often describe episodes in which patients appear to \"blank out\" or lose consciousness, become confused or behave in a bizarre manner, have speech or motor arrest, or become excessively somnolent. These episodes can last seconds to days, and they can be interspersed with periods of near-normal function,",
"   </p>",
"   <p>",
"    This feature of DLB has been considered the most difficult of the core clinical features for inexperienced clinicians to evaluate. Family members may not volunteer this history. At the same time, questions to elicit this history, if too general, are likely to obtain false positive responses in patients with other forms of dementia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Structured questionnaires (eg, Clinical Assessment of Fluctuation, One Day Fluctuation Assessment Scale) appear to more specifically elicit the symptoms of fluctuations in DLB. These share, as a common feature, the solicitation of more than one example of a fluctuation episode with specific descriptive details regarding symptoms, severity, and duration [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Episodes that include at least three of the four following features: daytime drowsiness, daytime naps lasting more than two hours, prolonged staring spells, and episodes of disorganized speech, are more likely to occur in patients with DLB than with AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/16\">",
"     16",
"    </a>",
"    ]. Descriptions of fluctuations in AD are more usually vague, of good and bad days, and are often explained by external stressors, while the fluctuations in DLB are more often spontaneous, episodic, and seem to describe an interruption of awareness or attention that impacts on functional ability [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An objective measure of fluctuations in DLB using computerized assessments of reaction time and vigilance has been shown to distinguish patients with DLB from Vascular Dementia and AD, but this is not a generally available clinical assessment tool [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Visual hallucinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual hallucinations occur in approximately two-thirds of patients with DLB, and are relatively rare in AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. These are also an early sign in DLB and may precede parkinsonism. In one study with neuropathologic confirmation, visual hallucinations at presentation was the most useful clinical feature to distinguish DLB from AD, with 83 percent positive predictive value [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Descriptions range from well-formed images of people or animals, to more abstract visions such as shapes or colors. Patients have described such simple hallucinations as seeing something briefly out of the corner of their eye, or extremely complex hallucinations, such as an ongoing dialog with a deceased loved one. Patients may also describe visual misperceptions, in which an object seems to move, zoom toward or away from the patient, or change shape.",
"   </p>",
"   <p>",
"    If not specifically solicited, visual hallucinations are often under reported. Patients may or may not have insight into the nature of the hallucinations or illusions, and reactions may vary from fear to indifference to enjoyment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42569?source=see_link&amp;anchor=H9#H9\">",
"     \"Approach to the patient with visual hallucinations\", section on 'Neurodegenerative disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Parkinsonism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parkinsonian symptoms, brady- and akinesia, limb rigidity,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    gait disorder, are seen in approximately 70 to 90 percent of patients with DLB, and they can be as severe as in idiopathic Parkinson disease (PD) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/21,23\">",
"     21,23",
"    </a>",
"    ]. However, parkinsonian features are usually more bilaterally symmetric and milder than in PD in most, although not all, studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/24\">",
"     24",
"    </a>",
"    ]. Tremor may also occur, but it is much less common and less severe than in PD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Despite these observed clinical trends, no individual symptom characteristic reliably distinguishes the motor parkinsonism of PD versus DLB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15943?source=see_link&amp;anchor=H3#H3\">",
"     \"Bradykinetic movement disorders in children\", section on 'Parkinson disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Suggestive features",
"    </span>",
"    &nbsp;&mdash;&nbsp;These features include REM sleep disorder, severe neuroleptic sensitivity, and low dopamine transporter uptake in the basal ganglia on single photon emission computed tomography (SPECT) or positron-emission tomography (PET) (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ). The presence of one of these in combination with one core clinical feature supports the diagnosis of probable DLB. The presence of one or more suggestive features in the absence of a core clinical feature suggests possible DLB.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     REM sleep disorder",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rapid eye movement (REM) sleep behavior disorder is a parasomnia characterized by vivid dreams in REM sleep without the usual accompanying muscle atonia. This causes individuals to \"act out\" their dreams, especially when they are vivid or frightening. These dream-enacting or oneiric behaviors can lead to injury to the patient or their bed partner, especially if the dream entails fleeing from or fighting with an attacker. While violent behaviors are often reported, a variety of nonviolent behaviors (eg, making speeches, feeding, sexual behaviors, urinating, defecating, clapping) are also common [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/27\">",
"     27",
"    </a>",
"    ]. The patient may not remember the episode.",
"   </p>",
"   <p>",
"    REM sleep behavior is commonly associated with DLB, occurring in 85 percent of individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/28\">",
"     28",
"    </a>",
"    ]. Some data suggests that it sufficiently common in DLB to be a core rather than a suggestive clinical feature [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/29\">",
"     29",
"    </a>",
"    ]. It is also prevalent in PD (15 percent) and multiple systems atrophy (70 percent); it is less common in other neurodegenerative diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/28,30-32\">",
"     28,30-32",
"    </a>",
"    ]. Rarely, it has been reported as an acute sequela of a focal ischemic or demyelinating lesion in the dorsal pons, and also in limbic encephalitis; however, a neuroanatomic localization in DLB has not been defined [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/33-35\">",
"     33-35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    REM sleep disorder may also be an independent, idiopathic condition. However, some caution should be applied in making this diagnosis as REM sleep disorder may precede other symptoms of DLB by many years (even decades) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/36-41\">",
"     36-41",
"    </a>",
"    ]. In one study of 44 patients with idiopathic REM sleep disorder, almost half developed DLB or another neurodegenerative disease after a mean 11.5 years of follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/38\">",
"     38",
"    </a>",
"    ]. In another follow-up study of 93 patients, the estimated risk of developing a neurodegenerative disorder was 18 percent at 5 years, 41 percent at 10 years and 52 percent at 12 years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/42\">",
"     42",
"    </a>",
"    ]. Careful examination may reveal early signs of neurodegenerative disease in patients with apparent idiopathic REM sleep disorder:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, about half of patients with idiopathic REM sleep disorder also had evidence of early clinical markers of parkinsonism (eg, autonomic symptoms, impaired motor and gait speed) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In other case series of patients with idiopathic REM sleep disorder, testing revealed abnormalities on single photon emission CT scanning that are similar to patients with Parkinson disease [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/44,45\">",
"       44,45",
"      </a>",
"      ] and evidence of sympathetic cardiac denervation on 123-I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy studies that is similar to that seen in patients with DLB [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/46\">",
"       46",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Radiologic features'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Other case series found that patients with idiopathic REM sleep disorder showed abnormalities on neuropsychologic testing similar to that seen in patients with early DLB,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      consistent with mild cognitive impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/47,48\">",
"       47,48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prognostic significance of any of these findings is uncertain. However, one study of 64 patients with idiopathic REM sleep disorder, impaired olfaction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    color vision measured every five years predicted future PD, dementia, or DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/49\">",
"     49",
"    </a>",
"    ]. Disease free survival was 70 percent for those with normal color vision and 26 percent for those with impaired color vision; disease free survival was 86 percent for those with normal olfaction and 35 percent for those with impaired olfaction.",
"   </p>",
"   <p>",
"    Most patients with REM sleep disorder respond to treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"     clonazepam",
"    </a>",
"    or melatonin. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=see_link&amp;anchor=H7685205#H7685205\">",
"     \"Prognosis and treatment of dementia with Lewy bodies\", section on 'Other psychotropic medications'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other sleep disorders that may be seen with DLB include insomnia, daytime hypersomnolence, sleep apnea (obstructive or central), periodic limb movements of sleep, and restless legs syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/50\">",
"     50",
"    </a>",
"    ]. These are not diagnostic features of DLB, but are important to recognize as effective treatments exist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Neuroleptic sensitivity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 30 to 50 percent of individuals with DLB have severe sensitivity to neuroleptics [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/51-53\">",
"     51-53",
"    </a>",
"    ]. Acute reactions include severe, sometimes irreversible parkinsonism and impaired consciousness, sometimes with other features suggestive of neuroleptic malignant syndrome. This can occur in individuals without baseline parkinsonism. This is more common with conventional agents, but reactions to newer drugs have also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/54\">",
"     54",
"    </a>",
"    ]. It is not dose-related. Neuroleptic medications may also precipitate or worsen confusion or autonomic dysfunction, and their use has been associated with a two to three-fold increase in mortality.",
"   </p>",
"   <p>",
"    Severe reactions to neuroleptics are less common in patients with Parkinson disease (with or without dementia), but have not been described in AD. Despite the high specificity of this finding, deliberate pharmacologic challenge as a diagnostic strategy is obviously unwise. A history of neuroleptic tolerance does not exclude DLB or future neuroleptic sensitivity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Supportive features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following clinical features are common in DLB but do not have clear diagnostic specificity (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Repeated falls",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent falls occur in up to a third of patients with DLB and may be among the earliest symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/55\">",
"     55",
"    </a>",
"    ]. Falls may seem to occur with or without provocation and may be related to parkinsonism, to cognitive fluctuations, or to orthostatic hypotension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Syncope or transient loss of consciousness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of altered or loss of consciousness are commonly described. Patients may transiently lose consciousness, or they may be awake but mute and staring blankly. Episodes may even resemble cataplexy, in which patients develop sudden atonia and fall to the floor.",
"   </p>",
"   <p>",
"    These can occur as a result of orthostatic hypotension, which has been reported in 28 to 50 percent of patients, and which can be severe enough to mimic multiple systems atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. In one series, 6 of 20 patients with DLB followed for three years required medication for blood pressure maintenance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/57\">",
"     57",
"    </a>",
"    ]. Carotid sinus sensitivity has also been described in association with DLB and may underlie episodes of syncope, or may be a general marker of autonomic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Episodes may also represent an extreme cognitive fluctuation or may be analogous to the motor \"freezing\" seen in idiopathic PD. Other etiologies such as seizures, stroke, transient ischemic attack, or cardiac arrhythmia should also be ruled out.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Autonomic dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to orthostatic hypotension and neurocardiovascular instability discussed above, autonomic dysfunction in DLB may include urinary incontinence or retention, constipation and other gastrointestinal symptoms, and impotence [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. Autonomic symptoms are more prevalent and severe than in PD, but less than in multiple systems atrophy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/57\">",
"     57",
"    </a>",
"    ]. Urinary incontinence occurs at late stages of AD when dementia is severe but is often an early sign in DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some small case series suggest that tests of autonomic dysfunction (eg, sympathetic sweat responses, skin vasomotor reflexes, head-up tilt, ventilatory response to hypercapnia, and heart rate variability) are likely to be markedly abnormal in patients with DLB and may help differentiate these patients from individuals with other neurodegenerative dementias [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/61,62\">",
"     61,62",
"    </a>",
"    ]. However, this diagnostic approach requires independent, prospective validation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Hallucinations in other modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to visual hallucinations, patients with DLB may also experience hallucinations in other modalities. Auditory hallucinations may be well formed, such as hearing identifiable speech or music, or they may be less distinct, such as having the impression of hearing a television, voice, or telephone ringing in another room. Olfactory hallucinations can be pleasant (eg, flowers or food) or unpleasant (eg, burning rubber). Patients have described tactile hallucinations such as the feeling of insects on their skin, or a cat brushing against their leg. The presence of these hallucinations may also prompt a workup for partial seizures, psychotic disorders, or substance intoxication or withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Systematized delusions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Delusions (false, fixed beliefs) occur commonly in DLB (in as many as 75 percent of cases) and may be elaborate, specific, and systematic [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/63\">",
"     63",
"    </a>",
"    ]. They are often rooted in hallucinations or visual misperceptions that the patient has experienced. Common themes include: the spouse or caregiver is an impostor, the house is not their home, or people in the television or mirror are speaking to them or following them.",
"   </p>",
"   <p>",
"    Somatoform disorder (characterized by a high frequency of medically unexplained symptoms) is a related but distinct psychiatric syndrome that may be observed in patients with DLB. In one study, 12 percent (15 of 124) of patients with DLB exhibited symptoms of somatization [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/64\">",
"     64",
"    </a>",
"    ]. The observed symptoms often took on delusional qualities (body deformation, requests for invasive medical procedures) and were associated with motor catatonic signs in eight patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients with DLB experience depressive symptoms at some point in their illness, and up to 40 percent have a major depressive episode. This is similar to the rate in PD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/65\">",
"     65",
"    </a>",
"    ], but higher in one study than the rate seen in AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/66\">",
"     66",
"    </a>",
"    ]. Depression is less likely than other features of DLB to persist over time [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     RADIOLOGIC FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiologic features are not essential to the diagnosis of DLB, but may provide supporting evidence (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;While generalized atrophy and white matter lesions are nonspecific findings in dementia, magnetic resonance imaging (MRI) may identify patterns of regional atrophy that are more specific to DLB. In particular, MRI coronal sections through the hippocampi usually show a greater degree of hippocampal atrophy in Alzheimer disease (AD) compared with DLB (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61076 \" href=\"UTD.htm?3/25/3475\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/67-69\">",
"     67-69",
"    </a>",
"    ]. In one study, volumetric analysis of MRI scans found that patients with DLB had more pronounced cortical atrophy than did patients with Parkinson disease dementia (PDD) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/70\">",
"     70",
"    </a>",
"    ]. However, it seems unlikely that this observation is sufficiently sensitive and specific to aid in diagnosis of DLB versus PDD in individual patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/71\">",
"     71",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Volumetric analyses of MRI scans have also suggested atrophy of the putamen and dorsal mesopontine gray matter in DLB compared with AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/69,72\">",
"     69,72",
"    </a>",
"    ]. Despite the changes in the occipital lobe on functional imaging discussed below, regional occipital atrophy is generally not observed on MRI in DLB. However, one study did report that a finding of reduced fractional anisotropy in the parieto-occipital white matter tracts on diffusion tensor imaging was associated with DLB and not AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     SPECT and PET studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-photon emission computed tomography (SPECT) and positron emission tomography (PET) scans show generalized decreased perfusion and metabolism, respectively, which is most noticeable in the occipital areas [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/74-80\">",
"     74-80",
"    </a>",
"    ]. The changes in the occipital lobe appear, at least in small series, to have potential diagnostic utility in DLB, with a sensitivity and specificity for SPECT of 65 and 87 percent and for PET of 90 and 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/75,81\">",
"     75,81",
"    </a>",
"    ]. This requires independent validation.",
"   </p>",
"   <p>",
"    Using specific ligands for dopamine transporter, SPECT and PET studies have demonstrated low dopaminergic activity in the striatum in DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/82-88\">",
"     82-88",
"    </a>",
"    ]. This is also seen in PD, multiple systems atrophy, and progressive supranuclear palsy, but not in AD. A study in 326 patients with dementia reported a sensitivity of 78 percent and a specificity of 90 percent of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/4/21572?source=see_link\">",
"     ioflupane I-123",
"    </a>",
"    dopamine transporter SPECT imaging (DaTscan) for the diagnosis of DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/89\">",
"     89",
"    </a>",
"    ]. This test result is considered a suggestive feature in the diagnosis of probable or possible DLB (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Suggestive features'",
"    </a>",
"    above) (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ). However, this technique is not widely available for clinical use.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Myocardial scintigraphy",
"    </span>",
"    &nbsp;&mdash;&nbsp;123-I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy demonstrates low uptake in DLB, representing reduced postganglionic sympathetic cardiac innervation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/90,91\">",
"     90,91",
"    </a>",
"    ]. In small series, this test appeared to have high sensitivity and specificity for DLB, especially when distinguishing it from AD. As an example, in one series, a heart to mediastinum uptake ratio of 1.68 had a sensitivity, specificity, and positive predictive value of 100 percent in discriminating between 37 patients with DLB and 42 patients with AD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/92\">",
"     92",
"    </a>",
"    ]. Similar abnormalities are also seen in PD, but not in multiple systems atrophy, progressive supranuclear palsy, or corticobasal ganglionic degeneration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The primary entity considered in the differential diagnosis for DLB is Alzheimer disease (AD). Other considerations include Parkinson disease (PD), vascular dementia, other degenerative dementias, and certain psychiatric disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/93\">",
"     93",
"    </a>",
"    ]. The clinical features which are useful in distinguishing among these disorders are discussed above (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical features'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Parkinson disease dementia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differentiation of Parkinson disease dementia (PDD) and Dementia with Lewy bodies (DLB) is somewhat arbitrary [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/94\">",
"     94",
"    </a>",
"    ]. In PDD, dementia occurs in the setting of well established parkinsonism, while in DLB, dementia usually occurs concomitantly with or before the development of parkinsonian signs. If parkinsonism is present for more than one year before the onset of dementia, it is officially classified as PDD. This arbitrary \"one-year rule\" may be an artificial distinction; the length of time that parkinsonism precedes other symptoms in otherwise similar patients does not correlate with pathologic differences [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/93\">",
"     93",
"    </a>",
"    ]. On the other hand, in one quantitative morphometric MRI study, patients with DLB had more pronounced cortical atrophy compared with patients with PDD, despite a similar severity of dementia in both groups [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/70\">",
"     70",
"    </a>",
"    ]. Another study also found that patients with PDD and DLB with similar severities of dementia could be distinguished by patterns of fractional anisotropy on diffuse tensor imaging MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/95\">",
"     95",
"    </a>",
"    ]. In contrast, a positron emission tomography study using dopaminergic and cholinergic tracers found that PDD and DLB appeared similar [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other features that may help distinguish between DLB and PDD are an older age of onset, faster clinical decline, and decreased levodopa responsivity for DLB compared with PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/97\">",
"     97",
"    </a>",
"    ]. Other clinical characteristics don't clearly distinguish well between DLB and PDD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/22\">",
"     22",
"    </a>",
"    ]. Parkinson disease dementia is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=see_link\">",
"     \"Parkinson disease dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Other dementia syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;When superimposed on AD or other degenerative dementias, delirium (from medication effects, systemic illness, or other metabolic abnormalities) may mimic some symptoms of DLB, including fluctuations and hallucinations. Fluctuations in a demented individual may be due to transient ischemic attack, seizure, or cardiac arrhythmia, rather than as a manifestation of DLB. Similarly, extrapyramidal side effects of medications should be considered as a potential cause of parkinsonism in patients with dementia. There is substantial clinical as well as pathologic overlap between AD and DLB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=see_link&amp;anchor=H5#H5\">",
"     \"Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies\", section on 'Clinical pathologic correlations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Creutzfeldt-Jakob disease (CJD) and DLB can have similar presentations. Prominent visual disturbances can present as an early sign in some forms of CJD, and myoclonus is sometimes a feature of DLB. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30698?source=see_link\">",
"     \"Creutzfeldt-Jakob disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Normal pressure hydrocephalus (NPH) presents with cognitive decline, urinary incontinence, and gait disorder; all of these are features of DLB. Psychiatric symptoms, sleep disorder, and other dysautonomic manifestations are absent in NPH. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14762?source=see_link\">",
"     \"Normal pressure hydrocephalus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The evaluation of a patient with dementia first establishes the presence of cognitive impairment and provides a measure of its severity. Treatable conditions are excluded. In general, this evaluation includes a cognitive assessment (Mini-Mental State Examination or formal neuropsychological testing), a neuroimaging study (usually magnetic resonance imaging), and laboratory evaluations (vitamin B12 level and thyroid function tests). This topic is discussed in more detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=see_link\">",
"     \"Evaluation of cognitive impairment and dementia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other ancillary studies are not routinely indicated but may be needed depending on the clinical picture. Electroencephalography (EEG) may be helpful if there is a question of seizures or of Creutzfeldt-Jakob disease (CJD). In DLB, the tracing may appear normal or nonspecifically abnormal with diffuse slowing, disorganization of the background rhythm, and temporal lobe transient sharp waves; frontal intermittent rhythmic delta activity (FIRDA) has also been described [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/93,98\">",
"     93,98",
"    </a>",
"    ]. Video-monitored electroencephalogram (EEG) may be useful to rule out seizures in the evaluation of cognitive fluctuations or staring spells. Polysomnography may be useful in evaluating sleep disorders. Other tests to evaluate the possibility of transient ischemic attack or syncope may be indicated in some patients with severe fluctuations or episodic loss of consciousness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/11/10426?source=see_link\">",
"     \"Initial evaluation and management of transient ischemic attack and minor stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=see_link\">",
"     \"Evaluation of syncope in adults\"",
"    </a>",
"    .) SPECT scanning using the dopamine transporter ligand",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/4/21572?source=see_link\">",
"     ioflupane I-123",
"    </a>",
"    (DaTscan) can provide support for the diagnosis of DLB in cases when the clinical features are suggestive but not diagnostic [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/99\">",
"     99",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'SPECT and PET studies'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    A positive diagnosis of DLB is primarily based upon clinical history and examination. Several autopsy-confirmed studies have shown that clinical diagnostic criteria provide a high specificity (0.87 to 1.0), but low sensitivity (0.22 to 0.65) for the pathologic diagnosis of DLB [",
"    <a class=\"abstract\" href=\"UTD.htm?1/55/1914/abstract/24,100-106\">",
"     24,100-106",
"    </a>",
"    ]. An effort to improve the sensitivity of the clinical diagnosis is represented by the revised criteria of the third report of the DLB consortium (",
"    <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"     table 1",
"    </a>",
"    ). These have not been validated.",
"   </p>",
"   <p>",
"    The clinical and radiologic features which distinguish DLB from AD and other dementias are most useful earlier in the course of the disease. In late stages, the clinical features of most dementia syndromes are more similar than different.",
"   </p>",
"   <p>",
"    The biggest barrier to the diagnosis of DLB is a low index of suspicion. The cardinal features of DLB which suggest the diagnosis may not be volunteered by patients or caregivers and often require specific solicitation by the clinician.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/3/18482?source=see_link\">",
"       \"Patient information: Dementia with Lewy bodies (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=see_link\">",
"       \"Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)\"",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dementia with Lewy bodies (DLB) is the second most common form of degenerative dementia after Alzheimer disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      DLB is characterized clinically by deficits in attention and visuospatial function; fluctuating cognition; recurrent visual hallucinations; and spontaneous motor features of parkinsonism. Other associated symptoms include repeated falls, syncope, autonomic dysfunction, neuroleptic sensitivity, delusions, hallucinations in other modalities, sleep disorders, and depression (",
"      <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of DLB requires a high index of suspicion and specific solicitation of cardinal features, which may not be volunteered by patients or caregivers. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of DLB includes other degenerative dementias, especially if complicated by superimposed delirium, medication toxicity, or seizures. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of DLB is made primarily by clinical criteria (",
"      <a class=\"graphic graphic_table graphicRef71071 \" href=\"UTD.htm?17/53/18269\">",
"       table 1",
"      </a>",
"      ). Radiologic features may also aid in the diagnosis, but are not required. For any individual clinical feature, the specificity is greater than the sensitivity for DLB. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional testing (blood work, electroencephalogram) is frequently indicated to rule out delirium or seizure as a cause or contributor to a patient's symptoms. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/1\">",
"      McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005; 65:1863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/2\">",
"      Salmon DP, Galasko D, Hansen LA, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996; 31:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/3\">",
"      Simard M, van Reekum R, Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 2000; 12:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/4\">",
"      Ballard CG, Ayre G, O'Brien J, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 1999; 10:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/5\">",
"      Aarsland D, Litvan I, Salmon D, et al. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003; 74:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/6\">",
"      Calderon J, Perry RJ, Erzinclioglu SW, et al. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/7\">",
"      Tiraboschi P, Salmon DP, Hansen LA, et al. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain 2006; 129:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/8\">",
"      Mondon K, Gochard A, Marqu&eacute; A, et al. Visual recognition memory differentiates dementia with Lewy bodies and Parkinson's disease dementia. J Neurol Neurosurg Psychiatry 2007; 78:738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/9\">",
"      Ala TA, Hughes LF, Kyrouac GA, et al. Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001; 70:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/10\">",
"      Gnanalingham KK, Byrne EJ, Thornton A. Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes. Lancet 1996; 347:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/11\">",
"      Mori E, Shimomura T, Fujimori M, et al. Visuoperceptual impairment in dementia with Lewy bodies. Arch Neurol 2000; 57:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/12\">",
"      Mosimann UP, Mather G, Wesnes KA, et al. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004; 63:2091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/13\">",
"      Bradshaw JM, Saling M, Anderson V, et al. Higher cortical deficits influence attentional processing in dementia with Lewy bodies, relative to patients with dementia of the Alzheimer's type and controls. J Neurol Neurosurg Psychiatry 2006; 77:1129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/14\">",
"      Mormont E, Laurier-Grymonprez L, Baisset-Mouly C, Pasquier F. [The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease]. Rev Neurol (Paris) 2003; 159:762.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/15\">",
"      McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/16\">",
"      Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology 2004; 62:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/17\">",
"      Bradshaw J, Saling M, Hopwood M, et al. Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct. J Neurol Neurosurg Psychiatry 2004; 75:382.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/18\">",
"      Walker MP, Ayre GA, Cummings JL, et al. The Clinician Assessment of Fluctuation and the One Day Fluctuation Assessment Scale. Two methods to assess fluctuating confusion in dementia. Br J Psychiatry 2000; 177:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/19\">",
"      Walker MP, Ayre GA, Cummings JL, et al. Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia. Neurology 2000; 54:1616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/20\">",
"      Ala TA, Yang KH, Sung JH, Frey WH 2nd. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1997; 62:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/21\">",
"      Strong C, Anderton BH, Perry RH, et al. Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct. Alzheimer Dis Assoc Disord 1995; 9:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/22\">",
"      Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology 2006; 67:1605.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/23\">",
"      Aarsland D, Ballard C, McKeith I, et al. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/24\">",
"      Mega MS, Masterman DL, Benson DF, et al. Dementia with Lewy bodies: reliability and validity of clinical and pathologic criteria. Neurology 1996; 47:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/25\">",
"      Galasko D, Katzman R, Salmon DP, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996; 31:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/26\">",
"      Burn DJ, Rowan EN, Allan LM, et al. Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2006; 77:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/27\">",
"      Oudiette D, De Cock VC, Lavault S, et al. Nonviolent elaborate behaviors may also occur in REM sleep behavior disorder. Neurology 2009; 72:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/28\">",
"      Paparrigopoulos TJ. REM sleep behaviour disorder: clinical profiles and pathophysiology. Int Rev Psychiatry 2005; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/29\">",
"      Ferman TJ, Boeve BF, Smith GE, et al. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology 2011; 77:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/30\">",
"      Boeve BF, Silber MH, Ferman TJ, et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001; 16:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/31\">",
"      Boeve BF, Lin SC, Strongosky A, et al. Absence of rapid eye movement sleep behavior disorder in 11 members of the pallidopontonigral degeneration kindred. Arch Neurol 2006; 63:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/32\">",
"      Weyer A, Minnerop M, Abele M, Klockgether T. REM sleep behavioral disorder in pure autonomic failure (PAF). Neurology 2006; 66:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/33\">",
"      Tippmann-Peikert M, Boeve BF, Keegan BM. REM sleep behavior disorder initiated by acute brainstem multiple sclerosis. Neurology 2006; 66:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/34\">",
"      Iranzo A, Graus F, Clover L, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2006; 59:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/35\">",
"      Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007; 130:2770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/36\">",
"      Turner RS, Chervin RD, Frey KA, et al. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology 1997; 49:523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/37\">",
"      Ferman TJ, Boeve BF, Smith GE, et al. Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations. J Int Neuropsychol Soc 2002; 8:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/38\">",
"      Iranzo A, Molinuevo JL, Santamar&iacute;a J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/39\">",
"      Postuma RB, Gagnon JF, Rompr&eacute; S, Montplaisir JY. Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease. Neurology 2010; 74:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/40\">",
"      Claassen DO, Josephs KA, Ahlskog JE, et al. REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 2010; 75:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/41\">",
"      Boot BP, Boeve BF, Roberts RO, et al. Probable rapid eye movement sleep behavior disorder increases risk for mild cognitive impairment and Parkinson disease: a population-based study. Ann Neurol 2012; 71:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/42\">",
"      Postuma RB, Gagnon JF, Vendette M, et al. Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder. Neurology 2009; 72:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/43\">",
"      Postuma RB, Lang AE, Massicotte-Marquez J, Montplaisir J. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006; 66:845.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/44\">",
"      Mazza S, Soucy JP, Gravel P, et al. Assessing whole brain perfusion changes in patients with REM sleep behavior disorder. Neurology 2006; 67:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/45\">",
"      Iranzo A, Lome&ntilde;a F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected]. Lancet Neurol 2010; 9:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/46\">",
"      Miyamoto T, Miyamoto M, Inoue Y, et al. Reduced cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder. Neurology 2006; 67:2236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/47\">",
"      Massicotte-Marquez J, D&eacute;cary A, Gagnon JF, et al. Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder. Neurology 2008; 70:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/48\">",
"      Gagnon JF, Vendette M, Postuma RB, et al. Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease. Ann Neurol 2009; 66:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/49\">",
"      Postuma RB, Gagnon JF, Vendette M, et al. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011; 69:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/50\">",
"      Boeve BF, Silber MH, Ferman TJ. Current management of sleep disturbances in dementia. Curr Neurol Neurosci Rep 2002; 2:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/51\">",
"      McKeith I, Fairbairn A, Perry R, et al. Neuroleptic sensitivity in patients with senile dementia of Lewy body type. BMJ 1992; 305:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/52\">",
"      Aarsland D, Perry R, Larsen JP, et al. Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. J Clin Psychiatry 2005; 66:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/53\">",
"      Ballard C, Grace J, McKeith I, Holmes C. Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease. Lancet 1998; 351:1032.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/54\">",
"      Walker Z, Grace J, Overshot R, et al. Olanzapine in dementia with Lewy bodies: a clinical study. Int J Geriatr Psychiatry 1999; 14:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/55\">",
"      Barber R, Panikkar A, McKeith IG. Dementia with Lewy bodies: diagnosis and management. Int J Geriatr Psychiatry 2001; 16 Suppl 1:S12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/56\">",
"      Horimoto Y, Matsumoto M, Akatsu H, et al. Autonomic dysfunctions in dementia with Lewy bodies. J Neurol 2003; 250:530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/57\">",
"      Thaisetthawatkul P, Boeve BF, Benarroch EE, et al. Autonomic dysfunction in dementia with Lewy bodies. Neurology 2004; 62:1804.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/58\">",
"      Kenny RA, Shaw FE, O'Brien JT, et al. Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions. J Neurol Neurosurg Psychiatry 2004; 75:966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/59\">",
"      Del-Ser T, Munoz DG, Hachinski V. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease. Neurology 1996; 46:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/60\">",
"      Ransmayr GN, Holliger S, Schletterer K, et al. Lower urinary tract symptoms in dementia with Lewy bodies, Parkinson disease, and Alzheimer disease. Neurology 2008; 70:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/61\">",
"      Akaogi Y, Asahina M, Yamanaka Y, et al. Sudomotor, skin vasomotor, and cardiovascular reflexes in 3 clinical forms of Lewy body disease. Neurology 2009; 73:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/62\">",
"      Mizukami K, Homma T, Aonuma K, et al. Decreased ventilatory response to hypercapnia in dementia with Lewy bodies. Ann Neurol 2009; 65:614.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/63\">",
"      Ballard CG, O'Brien JT, Swann AG, et al. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001; 62:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/64\">",
"      Onofrj M, Bonanni L, Manzoli L, Thomas A. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology 2010; 74:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/65\">",
"      Klatka LA, Louis ED, Schiffer RB. Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 1996; 47:1148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/66\">",
"      Ballard C, Holmes C, McKeith I, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 1999; 156:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/67\">",
"      Burton EJ, Karas G, Paling SM, et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage 2002; 17:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/68\">",
"      Barber R, Ballard C, McKeith IG, et al. MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 2000; 54:1304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/69\">",
"      Kantarci K, Ferman TJ, Boeve BF, et al. Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies. Neurology 2012; 79:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/70\">",
"      Beyer MK, Larsen JP, Aarsland D. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology 2007; 69:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/71\">",
"      Seppi K, Rascol O. Dementia with Lewy bodies and Parkinson disease with dementia: can MRI make the difference? Neurology 2007; 69:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/72\">",
"      Cousins DA, Burton EJ, Burn D, et al. Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer's disease: an MRI study. Neurology 2003; 61:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/73\">",
"      Watson R, Blamire AM, Colloby SJ, et al. Characterizing dementia with Lewy bodies by means of diffusion tensor imaging. Neurology 2012; 79:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/74\">",
"      Mirzaei S, Rodrigues M, Koehn H, et al. Metabolic impairment of brain metabolism in patients with Lewy body dementia. Eur J Neurol 2003; 10:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/75\">",
"      Lobotesis K, Fenwick JD, Phipps A, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology 2001; 56:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/76\">",
"      Pasquier J, Michel BF, Brenot-Rossi I, et al. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging 2002; 29:1342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/77\">",
"      Colloby SJ, Fenwick JD, Williams ED, et al. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping. Eur J Nucl Med Mol Imaging 2002; 29:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/78\">",
"      Firbank MJ, Colloby SJ, Burn DJ, et al. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003; 20:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/79\">",
"      Ceravolo R, Volterrani D, Gambaccini G, et al. Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. Neurol Sci 2003; 24:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/80\">",
"      Okamura N, Arai H, Higuchi M, et al. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/81\">",
"      Minoshima S, Foster NL, Sima AA, et al. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/82\">",
"      Hu XS, Okamura N, Arai H, et al. 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology 2000; 55:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/83\">",
"      Walker Z, Costa DC, Walker RW, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry 2002; 73:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/84\">",
"      Gilman S, Koeppe RA, Little R, et al. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Ann Neurol 2004; 55:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/85\">",
"      Colloby SJ, O'Brien JT, Fenwick JD, et al. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004; 23:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/86\">",
"      Ceravolo R, Volterrani D, Gambaccini G, et al. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study. J Neural Transm 2004; 111:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/87\">",
"      Walker Z, Jaros E, Walker RW, et al. Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J Neurol Neurosurg Psychiatry 2007; 78:1176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/88\">",
"      O'Brien JT, McKeith IG, Walker Z, et al. Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. Br J Psychiatry 2009; 194:34.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/89\">",
"      McKeith I, O'Brien J, Walker Z, et al. Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurol 2007; 6:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/90\">",
"      Yoshita M, Taki J, Yamada M. A clinical role for [(123)I]MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2001; 71:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/91\">",
"      Taki J, Yoshita M, Yamada M, Tonami N. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004; 18:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/92\">",
"      Yoshita M, Taki J, Yokoyama K, et al. Value of 123I-MIBG radioactivity in the differential diagnosis of DLB from AD. Neurology 2006; 66:1850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/93\">",
"      McKeith I, Mintzer J, Aarsland D, et al. Dementia with Lewy bodies. Lancet Neurol 2004; 3:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/94\">",
"      Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007; 68:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/95\">",
"      Lee JE, Park HJ, Park B, et al. A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2010; 81:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/96\">",
"      Klein JC, Eggers C, Kalbe E, et al. Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 2010; 74:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/97\">",
"      Molloy S, McKeith IG, O'Brien JT, Burn DJ. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2005; 76:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/98\">",
"      Roks G, Korf ES, van der Flier WM, et al. The use of EEG in the diagnosis of dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 2008; 79:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/99\">",
"      Kupsch AR, Bajaj N, Weiland F, et al. Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study. J Neurol Neurosurg Psychiatry 2012; 83:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/100\">",
"      Luis CA, Barker WW, Gajaraj K, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry 1999; 14:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/101\">",
"      Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. Br J Psychiatry 1999; 174:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/102\">",
"      Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 1999; 53:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/103\">",
"      Lopez OL, Litvan I, Catt KE, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999; 53:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/104\">",
"      McKeith IG, Ballard CG, Perry RH, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology 2000; 54:1050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/105\">",
"      Hohl U, Tiraboschi P, Hansen LA, et al. Diagnostic accuracy of dementia with Lewy bodies. Arch Neurol 2000; 57:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/55/1914/abstract/106\">",
"      Lopez OL, Becker JT, Kaufer DI, et al. Research evaluation and prospective diagnosis of dementia with Lewy bodies. Arch Neurol 2002; 59:43.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5088 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-6FA69E1D15-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1914=[""].join("\n");
var outline_f1_55_1914=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Core clinical features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Fluctuations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Visual hallucinations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Parkinsonism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Suggestive features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - REM sleep disorder",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Neuroleptic sensitivity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Supportive features",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Repeated falls",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Syncope or transient loss of consciousness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Autonomic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Hallucinations in other modalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Systematized delusions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      RADIOLOGIC FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      SPECT and PET studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Myocardial scintigraphy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Parkinson disease dementia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Other dementia syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5088\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5088|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?3/25/3475\" title=\"diagnostic image 1\">",
"      MRI Dementia with Lewy bodies versus Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5088|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/53/18269\" title=\"table 1\">",
"      Clinical features of DLB",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/36/42569?source=related_link\">",
"      Approach to the patient with visual hallucinations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15943?source=related_link\">",
"      Bradykinetic movement disorders in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/33/27162?source=related_link\">",
"      Clinical manifestations and diagnosis of Alzheimer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/62/30698?source=related_link\">",
"      Creutzfeldt-Jakob disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/41/34455?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of dementia with Lewy bodies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/57/37786?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/25/28057?source=related_link\">",
"      Evaluation of cognitive impairment and dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/15/18682?source=related_link\">",
"      Evaluation of syncope in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/20/12618?source=related_link\">",
"      Frontotemporal dementia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/11/10426?source=related_link\">",
"      Initial evaluation and management of transient ischemic attack and minor stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/26/14762?source=related_link\">",
"      Normal pressure hydrocephalus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/36/15946?source=related_link\">",
"      Parkinson disease dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/37/14934?source=related_link\">",
"      Patient information: Dementia (including Alzheimer disease) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/3/18482?source=related_link\">",
"      Patient information: Dementia with Lewy bodies (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/34/21031?source=related_link\">",
"      Prognosis and treatment of dementia with Lewy bodies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_55_1915="Motor neuron signs";
var content_f1_55_1915=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Signs of upper versus lower motor neuron disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Clinical",
"      </td>",
"      <td class=\"subtitle1\">",
"       UMN",
"      </td>",
"      <td class=\"subtitle1\">",
"       LMN",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Muscle tone",
"      </td>",
"      <td>",
"       Increased",
"      </td>",
"      <td>",
"       Decreased",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Reflexes",
"      </td>",
"      <td>",
"       Hyperreflexia",
"      </td>",
"      <td>",
"       Hyporeflexia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Babinski sign",
"      </td>",
"      <td>",
"       Present",
"      </td>",
"      <td>",
"       Absent",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     UMN: upper motor neuron; LMN: lower motor neuron.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1915=[""].join("\n");
var outline_f1_55_1915=null;
var title_f1_55_1916="High low sodium foods PI";
var content_f1_55_1916=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F74448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F74448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Ways to cut down on salt (sodium)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Avoid these foods",
"       </td>",
"       <td class=\"subtitle1\">",
"        Try these foods instead",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Cured and smoked foods such as bacon, sausage, hot dogs, ham, lunch meats, and corn beef",
"       </td>",
"       <td>",
"        Fresh turkey, chicken, and lean beef",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Canned fish (such as sardines)",
"       </td>",
"       <td>",
"        Unsalted tuna",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Canned meats",
"       </td>",
"       <td>",
"        Tofu",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Salted pretzels, crackers, potato chips, and nuts",
"       </td>",
"       <td>",
"        Low sodium and unsalted versions of these foods",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Most cheeses",
"       </td>",
"       <td>",
"        Low sodium cheeses",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        Sauces (tomato and cream etc), tomato juices",
"       </td>",
"       <td>",
"        Low sodium versions of these foods, such as low sodium tomato juice",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"4\">",
"        Processed, instant, and convenience foods such as frozen dinners, packaged meals, canned soups, and boxed pasta blends",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Cook and freeze your own low sodium meals, soups, and broths",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <ul>",
"         <li>",
"          If you must use convenience or processed foods, read the labels and choose items with 140-200 mg of sodium per serving per food, or",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <ul>",
"         <li>",
"          For an entire convenience meal (frozen dinner) try to stay under 500-600 mg sodium.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <ul>",
"         <li>",
"          If you do used canned foods, use \"sodium free\" varieties, or rinse the canned food under water. This reduces the sodium content by about 40 percent.",
"         </li>",
"        </ul>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1916=[""].join("\n");
var outline_f1_55_1916=null;
var title_f1_55_1917="Monitor during amiodarone";
var content_f1_55_1917=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F50410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F50410&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Amiodarone monitoring and recommendations",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"3\" width=\"15%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"27%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        System",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Monitoring",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Possible adverse effect",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Recommendation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Baseline",
"       </td>",
"       <td class=\"subtitle2\">",
"        Follow-up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Cardiac",
"       </td>",
"       <td rowspan=\"2\">",
"        ECG (at baseline and during loading dose)",
"       </td>",
"       <td rowspan=\"2\">",
"        Yearly",
"       </td>",
"       <td>",
"        QT prolongation; torsade de pointes",
"       </td>",
"       <td rowspan=\"2\">",
"        Reduce amiodarone dose or discontinue use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptomatic sinoatrial or conduction system impairment",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Dermatologic",
"       </td>",
"       <td rowspan=\"2\">",
"        Physical examination",
"       </td>",
"       <td rowspan=\"2\">",
"        As needed for signs/symptoms",
"       </td>",
"       <td>",
"        Photosensitivity to UV light",
"       </td>",
"       <td>",
"        Avoid sunlight; use sunscreen",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blue-gray skin discoloration",
"       </td>",
"       <td>",
"        Reduce amiodarone dose or discontinue use",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Endocrine",
"       </td>",
"       <td rowspan=\"2\">",
"        Thyroid function tests",
"       </td>",
"       <td rowspan=\"2\">",
"        Every 6 months",
"       </td>",
"       <td>",
"        Hyperthyroidism",
"       </td>",
"       <td>",
"        Discontinue amiodarone; refer to endocrinologist",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypothyroidism",
"       </td>",
"       <td>",
"        Treat with levothyroxine",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Hepatic",
"       </td>",
"       <td>",
"        AST or ALT",
"       </td>",
"       <td>",
"        Every 6 months",
"       </td>",
"       <td>",
"        AST or ALT elevation &ge;2x upper limit of reference range",
"       </td>",
"       <td>",
"        Reduce amiodarone dose or discontinue use",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Neurologic",
"       </td>",
"       <td>",
"        Physical examination",
"       </td>",
"       <td>",
"        As needed for signs/symptoms",
"       </td>",
"       <td>",
"        Ataxia, dizziness, fatigue",
"       </td>",
"       <td>",
"        Reduce amiodarone dose or discontinue use",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Ophthalmologic",
"       </td>",
"       <td rowspan=\"2\">",
"        Eye examination",
"       </td>",
"       <td rowspan=\"2\">",
"        As needed for signs/symptoms",
"       </td>",
"       <td>",
"        Corneal microdeposits",
"       </td>",
"       <td>",
"        Continue amiodarone treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Optic neuropathy",
"       </td>",
"       <td>",
"        Discontinue treatment",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Pulmonary",
"       </td>",
"       <td>",
"        Pulmonary function tests",
"       </td>",
"       <td>",
"        As needed for signs/symptoms",
"       </td>",
"       <td rowspan=\"2\">",
"        Pulmonary toxicity (cough, fever, dyspnea)",
"       </td>",
"       <td rowspan=\"2\">",
"        Discontinue amiodarone immediately; consider corticosteroid treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chest radiograph",
"       </td>",
"       <td>",
"        Yearly",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ALT: alanine aminotransferase; AST: aspartate aminotransferase; ECG: electrocardiogram.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Vassallo P, Trohman RG. Prescribing amiodarone: an evidence-based review of clinical indications. JAMA 2007; 298:1312. Copyright &copy; American Medical Association. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1917=[""].join("\n");
var outline_f1_55_1917=null;
var title_f1_55_1918="Incidence HCV by risk factor";
var content_f1_55_1918=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54694&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reported cases of acute hepatitis C by selected risk factors, United States, 1983-1998*",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 445px; height: 204px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * 1983-1990 based on non-A, non-B hepatitis.",
"    </div>",
"    <div class=\"reference\">",
"     Source: CDC Sentinel Counties Study.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1918=[""].join("\n");
var outline_f1_55_1918=null;
var title_f1_55_1919="Conceptual model for chronic kidney disease";
var content_f1_55_1919=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F77385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F77385&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 566px\">",
"   <div class=\"ttl\">",
"    Conceptual model for chronic kidney disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 546px; height: 262px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This diagram presents the continuum of development, progression and complications of chronic kidney disease (CKD) and strategies to improve outcomes. Green circles represent stages of CKD; aqua circles represent potential antecedents of CKD, lavender circles represent consequences of CKD; and thick arrows between circles represent the development, progression and remission of CKD. \"CKD\" is defined as the presence of either kidney damage or decreased kidney function for three or more months, irrespective of cause (underlying illness and pathology). \"Complications\" refers to all complications of CKD, including complications of decreased GFR, albuminuria and cardiovascular disease. Complications may also arise from adverse effects of interventions to prevent or treat the disease. The horizontal arrows pointing from left to right emphasize the progressive nature of CKD. Dashed arrowheads pointing from right to left signify that remission is less frequent than progression.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. From: Levey AS, Stevens LA, Coresh J. Conceptual model of CKD: applications and implications. Am J Kidney Dis 2009; 53:S4. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_55_1919=[""].join("\n");
var outline_f1_55_1919=null;
